Organic, including symptomatic, mental disorders

F5_ORGANIC

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints F5_DEMENTIA F5_ORGAMN F5_DELIRIUM F5_MENTORG F5_PERSBEHORG F5_UNSORG	36211
6. Filter based on genotype QC (FinnGen only)	35163

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	F5_ORGANIC
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_DEMENTIA\|F5_ORGAMN\|F5_DELIRIUM\|F5_MENTORG\|F5_PERSBEHORG\|F5_UNSORG
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Organic, including symptomatic, mental disorders based on the number of shared cases.

Similar with more cases:

Psychiatric diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	35163	16180	18983
Unadjusted period prevalence (%)	7.34	5.74	8.70
Median age at first event (years)	78.09	78.58	77.67

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
25643: Matched controls
182457

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

+∞

307.7

3804

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

8.6

307.7

6997

7611

R53

ICD-10 Finland

Malaise and fatigue

2.6

307.7

7741

26225

F29

ICD-10 Finland

Unspecified nonorganic psychosis

6.0

307.7

1062

1295

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

132.1

307.7

2361

140

L28

ICPC

Limited function/disability (L)

2.4

307.7

6552

22947

N05BA04

ATC

oxazepam; oral

2.4

307.7

7848

28464

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

307.7

8585

36715

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

911.1

307.7

625

SPAT1301

SPAT

No procedures

1.8

307.7

8993

41450

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

42.2

307.7

597

103

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.3

307.7

2189

4964

N05AX08

ATC

risperidone; systemic

13.0

307.7

5981

4172

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

43.6

307.7

321

N05AH03

ATC

olanzapine; systemic

5.4

307.7

2222

3163

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

104.6

307.7

3595

284

F0019, G301,

ICD-10 Finland

+∞

307.7

430

SPAT1245

SPAT

Provision of support and information to patient’s family members

5.6

307.7

2457

3369

SPAT1254

SPAT

Administration of medicine

2.6

307.7

5359

16791

S06.0

ICD-10 Finland

Concussion

2.4

307.7

3007

9688

N06DA04

ATC

galantamine; oral

219.5

307.7

2656

AA1AD

NOMESCO Finland

CT of head and brain

2.6

307.7

10317

37100

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

307.7

10384

41035

WYA20

NOMESCO Finland

Home visit

8.3

307.7

887

783

G20

ICD-10 Finland

Parkinson disease

4.3

307.7

1616

2817

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.9

307.7

1890

4856

N06DA03

ATC

rivastigmine; oral, transdermal

248.1

307.7

5423

197

N06AX26

ATC

vortioxetine; oral

3.4

307.7

1645

3609

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.2

307.7

1293

2253

TAB00

NOMESCO Finland

Lumbar puncture

5.3

307.7

1705

2418

F06.0

ICD-10 Finland

Organic hallucinosis

175.3

307.7

244

S72.0

ICD-10 Finland

Fracture of neck of femur

3.1

307.7

1649

3957

A04

ICPC

Weakness/tiredness general

2.3

307.7

4480

15399

SPAT1101

SPAT

Orthostatic test

3.0

307.7

1758

4314

F05.9

ICD-10 Finland

Delirium, unspecified

177.8

307.7

2846

128

P20

ICPC

Memory disturbance

10.1

307.7

11073

12757

U04

ICPC

Incontinence urine

3.0

307.7

2025

5140

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.1

307.7

2110

5188

G30.1

ICD-10 Finland

Alzheimer disease with late onset

109.8

307.7

7489

683

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

140.3

307.7

331

G30

ICD-10 Finland

Alzheimer disease

146.8

307.7

1030

A06AD11

ATC

lactulose; oral

2.2

307.7

5391

19483

R41.0

ICD-10 Finland

Disorientation, unspecified

7.7

307.7

2030

2007

N06DX01

ATC

memantine; oral

309.6

307.7

9869

368

N03AG01

ATC

valproic acid; systemic, rectal

5.2

307.7

2390

3527

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

243.7

307.7

3721

127

N05AH04

ATC

quetiapine; oral

4.8

307.7

6525

12092

SPAT1304

SPAT

Counselling and guidance related to ageing

2.5

307.7

2909

9041

SPAT1229

SPAT

Assessment of need for aid

2.5

307.7

2835

8632

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

307.7

4324

16284

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

7.6

307.7

701

670

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

213.0

307.7

585

F06.7

ICD-10 Finland

Mild cognitive disorder

28.2

307.7

3183

911

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.7

307.7

5889

18392

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

307.7

5314

17206

N05AD01

ATC

haloperidol; systemic

4.9

307.7

1423

2177

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.2

307.7

1761

4085

S01.0

ICD-10 Finland

Open wound of scalp

2.6

307.7

2622

7788

N06AB10

ATC

escitalopram; oral

2.2

307.7

4247

15328

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.6

307.7

2534

7263

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.7

307.7

7512

24059

F05.8

ICD-10 Finland

Other delirium

205.9

307.7

867

G30.8

ICD-10 Finland

Other Alzheimer disease

93.7

307.7

2270

189

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

567.4

307.7

1070

XA800

NOMESCO Finland

Neuropsychological investigation

5.4

307.7

1609

2241

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.0

307.7

2274

5739

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.6

307.7

3142

9147

AXX01, ,

SPAT

4.0

307.7

1382

2536

F05.1

ICD-10 Finland

Delirium superimposed on dementia

1328.3

307.7

569

I95.1

ICD-10 Finland

Orthostatic hypotension

3.4

307.7

1666

3673

SPAT1216

SPAT

Assessment of functional ability

2.9

307.7

6608

19211

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

6.2

307.7

651

767

F01.9

ICD-10 Finland

Vascular dementia, unspecified

67.9

307.7

1228

135

SPAT1234

SPAT

Support of social functional capacity

4.6

307.7

2582

4298

N87

ICPC

Parkinsonism

6.1

307.7

809

963

A28

ICPC

Limited function/disability NOS

3.5

307.7

8307

22091

F03

ICD-10 Finland

Unspecified dementia

58.2

307.7

4582

679

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

431.4

307.7

650

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

4.3

307.7

1451

2512

F01.2

ICD-10 Finland

Subcortical vascular dementia

42.1

307.7

316

G30.0

ICD-10 Finland

Alzheimer disease with early onset

173.3

307.7

939

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

4.5

307.7

1951

3302

R41.3

ICD-10 Finland

Other amnesia

6.5

307.7

1688

1965

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

4.1

307.7

4013

7969

N06AB04

ATC

citalopram; systemic

2.0

307.7

5461

22043

SPAT1053

SPAT

Memory test

4.7

307.7

8919

18515

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.4

307.7

1620

3525

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.7

307.7

2845

8165

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

113.2

307.7

252

P70

ICPC

Dementia

43.4

307.7

2121

378

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

22.9

307.7

399

126

N05BA06

ATC

lorazepam; systemic, sublingual

3.3

307.7

1922

4391

G31.0

ICD-10 Finland

Circumscribed brain atrophy

16.5

307.7

342

149

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

309.7

307.7

428

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.0

307.7

3029

5850

N06AX11

ATC

mirtazapine; oral

2.1

307.7

9336

38666

N06DA02

ATC

donepezil; oral

203.9

307.7

7878

396

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

294.7

4468

17933

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

293.1

4853

20056

W19

ICD-10 Finland

Unspecified fall

2.2

290.0

2885

9882

R55

ICD-10 Finland

Syncope and collapse

2.0

287.7

3585

13410

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.7

282.9

1036

2063

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

282.4

3741

14302

N02AA05

ATC

oxycodone; systemic

1.8

281.9

5458

23665

R42

ICD-10 Finland

Dizziness and giddiness

1.7

278.1

6604

30386

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

6.6

274.1

514

562

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

281.5

271.3

314

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

271.3

3652

14026

SPAT1172

SPAT

Guidance concerning hydration

3.7

269.6

989

1971

F00

ICD-10 Finland

Dementia in Alzheimer disease

42.4

268.8

213

SPAT1252

SPAT

Overall medication plan or its review

2.3

264.9

2273

7295

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

3.5

253.7

1004

2108

F06.32

ICD-10 Finland

Organic depression

41.4

253.7

202

C03CA01

ATC

furosemide; systemic

1.6

250.1

10131

53145

N05AX12

ATC

aripiprazole; systemic

4.2

249.3

752

1293

F009, G309,

ICD-10 Finland

+∞

247.0

271

N04BD01

ATC

selegiline; oral

4.8

244.6

635

962

Z2445

NOMESCO Finland

Psychologist

3.7

242.4

861

1676

A29

ICPC

General symptom/complaint other

1.9

241.1

3544

13988

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

4.1

233.3

727

1282

T90.5

ICD-10 Finland

Sequelae of intracranial injury

6.2

228.9

454

528

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

222.9

1677

5055

N06AB06

ATC

sertraline; oral

2.2

222.3

2293

7928

N05AA02

ATC

levomepromazine; systemic

2.9

221.8

1159

2890

N03AX09

ATC

lamotrigine; oral

3.3

216.2

943

2108

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

49.2

213.8

165

SPAT1360

SPAT

Extensive global examination

2.2

211.2

2106

7176

F01

ICD-10 Finland

Vascular dementia

21.4

207.6

197

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.8

207.0

717

1369

E86

ICD-10 Finland

Volume depletion

3.2

206.1

905

2031

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

205.8

3438

14094

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.3

205.6

879

1939

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.6

204.5

754

1506

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.8

204.0

699

1324

Z75.5

ICD-10 Finland

Holiday relief care

6.7

203.9

376

403

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.0

203.9

669

1227

F07.2

ICD-10 Finland

Postconcussional syndrome

80.4

202.1

146

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

202.0

2145

7490

N02BE01

ATC

paracetamol; systemic, rectal

1.7

199.6

21832

140066

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

198.9

1874

6232

N03AX14

ATC

levetiracetam; systemic

3.2

197.9

887

2016

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

6.8

197.8

363

387

N30.0

ICD-10 Finland

Acute cystitis

1.8

197.4

3972

17209

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.8

196.5

415

516

SPAT1167

SPAT

Insertion of urinary catheter

2.7

195.3

1189

3221

N05AD03

ATC

melperone; systemic

4.9

194.1

488

718

N05AH02

ATC

clozapine; systemic

5.6

190.8

421

547

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.7

190.6

1200

3308

F21, ,

ICPC

6.2

187.8

374

437

P29

ICPC

Psychological sympt/compl other

2.7

186.1

1143

3110

N06AX16

ATC

venlafaxine; oral

1.9

185.8

2647

10276

F22.0

ICD-10 Finland

Delusional disorder

4.7

182.5

481

738

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

4.9

182.0

460

680

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.1

179.1

565

1005

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

1377.4

179.0

199

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.4

178.6

725

1545

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.6

178.5

667

1344

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.3

178.1

520

870

N05CD07

ATC

temazepam; oral

1.7

177.4

3624

15726

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.9

176.6

2558

9977

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

174.1

7447

38731

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

173.4

3855

17120

SPAT1263

SPAT

Sampling

1.5

173.3

9970

55074

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

172.9

2501

9746

R44.1

ICD-10 Finland

Visual hallucinations

8.9

172.3

255

206

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

352.1

171.8

197

SPAT1139

SPAT

Nutrition survey

2.8

171.7

970

2522

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.0

169.0

539

967

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

41.7

168.5

134

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

166.6

2999

12522

N04BD02

ATC

rasagiline; oral

5.9

166.3

345

421

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.3

166.1

699

1525

OAB43, ,

SPAT

0.3

165.5

453

10785

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

162.8

7479

39360

S70.0

ICD-10 Finland

Contusion of hip

2.5

162.0

1152

3370

N03AE01

ATC

clonazepam; systemic

2.2

161.8

1476

4831

N03AF02

ATC

oxcarbazepine; oral

2.9

160.9

872

2215

N05BA01

ATC

diazepam; systemic, rectal

1.7

159.3

3285

14256

Z29

ICPC

Social problem NOS

3.7

159.1

559

1078

G04BD12

ATC

mirabegron; oral

1.7

158.6

3455

15224

R33

ICD-10 Finland

Retention of urine

1.8

157.2

2608

10608

N05AN01

ATC

lithium; oral

3.7

157.1

557

1081

N04AA02

ATC

biperiden; systemic

3.8

157.1

537

1015

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.0

156.7

499

894

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.0

156.6

2019

7550

N29

ICPC

Neurological sympt/complt other

3.4

156.1

624

1316

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

421.9

155.4

177

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

155.0

1757

6269

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

+∞

154.8

170

C10AA01

ATC

simvastatin; oral

1.4

153.9

12406

72427

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

153.8

2453

9849

G72.8

ICD-10 Finland

Other specified myopathies

3.6

150.9

569

1153

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

150.3

1853

6817

R44.3

ICD-10 Finland

Hallucinations, unspecified

8.5

150.2

229

193

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

148.7

3822

17570

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

305.1

148.4

171

N05AB03

ATC

perphenazine; systemic, rectal

2.8

148.3

838

2178

193

Kela drug reimbursment

Rasagiline

6.5

147.7

278

305

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

6.0

147.5

299

356

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.7

146.6

3145

13777

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

1200.2

146.3

163

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

145.3

1371

4547

F06.4

ICD-10 Finland

Organic anxiety disorder

46.7

142.5

111

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.8

141.6

486

921

ZY000

NOMESCO Finland

Hospital inpatient

5.5

140.7

311

405

P15

ICPC

Chronic alcohol abuse

3.1

139.2

642

1483

AXX01

NOMESCO Finland

Memory assessment

17.7

138.5

141

R1250

NOMESCO Finland

Evaluation of functional capability

3.3

138.0

594

1314

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

137.8

1138

3563

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

136.5

1212

3916

G04CA02

ATC

tamsulosin; oral

1.4

136.0

7293

39266

P99

ICPC

Psychological disorders other

3.4

134.9

535

1122

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

539.7

133.5

151

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.6

133.4

490

975

F10.24

ICD-10 Finland

Alcohol depence active use

4.3

133.4

389

650

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

223.4

132.5

155

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.8

132.0

767

2023

S06.3

ICD-10 Finland

Focal brain injury

3.9

131.4

440

819

N27

ICPC

Fear of neurological disease other

3.3

131.1

543

1172

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.9

130.4

1987

7844

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.9

128.0

668

1660

SPAT1251

SPAT

Organisation of medication

2.4

127.6

1008

3092

N05CF01

ATC

zopiclone; oral

1.4

126.9

8221

45677

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

179.0

126.6

150

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

125.2

2394

10123

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

4.7

125.0

329

504

F0009, G300,

ICD-10 Finland

+∞

124.7

137

183

Kela drug reimbursment

Lamotrigin and topiramate

6.0

124.0

254

306

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

14.6

122.0

135

F01.8

ICD-10 Finland

Other vascular dementia

64.3

121.2

N03AX18

ATC

lacosamide; systemic

5.8

120.8

255

317

N28

ICPC

Limited function/disability (N)

3.2

120.2

523

1165

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

118.5

2033

8320

R5110, ,

SPAT

1.9

118.2

1788

7033

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

118.2

4880

46926

S00.0

ICD-10 Finland

Superficial injury of scalp

2.8

116.0

649

1676

OAB41

NOMESCO Finland

Guidance and counselling related to ageing

14.9

115.7

127

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.9

115.4

617

1554

N06AX21

ATC

duloxetine; oral

1.7

114.9

2277

9717

SPAT1262

SPAT

Handing over of treatment supplies

1.5

114.8

4507

22695

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

114.7

2509

11002

N03AF01

ATC

carbamazepine; oral, rectal

2.0

114.0

1304

4655

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.7

112.3

395

762

SPAT1050

SPAT

Extensive neurological examination

2.9

112.2

604

1527

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

111.6

3566

17163

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

111.5

6955

38191

R11

ICD-10 Finland

Nausea and vomiting

1.8

111.5

1992

8245

N04BC04

ATC

ropinirole; oral

3.8

111.2

377

708

K90

ICPC

Stroke/cerebrovascular accident

2.3

111.1

907

2822

F06.30

ICD-10 Finland

Organic manic syndrome

+∞

110.1

121

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

5.8

110.0

230

283

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

109.9

3159

14830

A10AB05

ATC

insulin aspart; parenteral

1.8

109.8

1839

7463

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

3.0

109.5

541

1302

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.4

109.4

441

935

G04CB01

ATC

finasteride; oral

1.5

107.8

3563

17264

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.2

107.7

255

355

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

4.5

107.2

293

464

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

107.1

6213

33643

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.2

106.7

474

1070

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

106.4

1815

7406

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.3

106.3

438

942

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

106.0

4030

20117

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

105.6

4461

22752

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.7

105.4

374

726

N17

ICPC

Vertigo/dizziness

1.6

105.4

3048

14319

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.3

104.9

438

950

OAB76

NOMESCO Finland

General guidance on nutrition and food

27.4

104.8

N07BB01

ATC

disulfiram; oral

2.4

104.4

810

2463

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

104.2

8470

48464

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

20.0

104.1

101

F01.1

ICD-10 Finland

Multi-infarct dementia

828.7

103.6

116

H02AA02

ATC

fludrocortisone; oral

4.4

103.5

293

478

SPAT1260

SPAT

Consultation of another employee

1.5

103.0

4228

21427

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

+∞

102.8

113

N05AF03

ATC

chlorprothixene; systemic

2.9

102.7

552

1394

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

102.5

1000

3354

J01EA01

ATC

trimethoprim; systemic

1.4

102.2

5921

32005

SPAT1240

SPAT

Therapeutic discussion

1.8

102.0

1606

6389

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.5

102.0

706

2034

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

413.7

101.9

116

F01.0

ICD-10 Finland

Vascular dementia of acute onset

145.4

101.6

122

IHZ08

NOMESCO Finland

Provision of support and information for patient’s relatives

24.3

101.2

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

101.1

1596

6355

B01AA03

ATC

warfarin; systemic

1.4

100.2

5861

31718

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

8.8

99.8

148

120

G40

ICD-10 Finland

Epilepsy

4.7

99.5

260

396

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.6

99.1

658

1858

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

208.3

98.9

116

S06.2

ICD-10 Finland

Diffuse brain injury

4.1

98.7

305

534

F0014, G301,

ICD-10 Finland

785.6

98.1

110

A27

ICPC

Fear of other disease NOS

2.0

97.9

1206

4418

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.6

97.7

362

725

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

267.9

97.6

113

K59.0

ICD-10 Finland

Constipation

1.9

97.2

1500

5928

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

96.5

6809

37979

N04BX02

ATC

entacapone; oral

6.6

95.8

179

195

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

95.1

9731

57421

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.8

94.3

241

360

Z28

ICPC

Limited function/disability (Z)

5.8

94.3

196

240

P72

ICPC

Schizophrenia

3.5

94.0

365

755

F01.80

ICD-10 Finland

Other specified vascular dementia without additional symptoms

47.4

93.9

G35

ICD-10 Finland

Multiple sclerosis

3.9

93.8

307

562

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

3.2

93.4

406

904

W06

ICD-10 Finland

Fall involving bed

4.0

93.0

293

521

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

92.3

1468

5854

N88

ICPC

Epilepsy

5.7

91.7

196

247

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.3

91.4

267

447

F001, G301,

ICD-10 Finland

251.1

91.3

106

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.6

91.0

2401

25509

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.1

90.9

976

3397

J01CA08

ATC

pivmecillinam; oral

1.3

90.6

7713

44203

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

89.7

3847

19610

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.7

89.4

235

360

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.7

89.4

315

609

30920

ICD-8 Finland

Mental disorders not specified as psychotic associated with physical conditions, Brain trauma

+∞

89.2

130

Kela drug reimbursment

Malignant tumour

0.5

89.1

903

12413

N99

ICPC

Neurological disease other

3.4

88.9

357

755

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.7

88.6

234

360

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

88.5

4430

23242

R25.1

ICD-10 Finland

Tremor, unspecified

2.2

88.5

803

2613

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

359.8

88.3

101

R32

ICD-10 Finland

Unspecified urinary incontinence

2.3

88.0

754

2394

ICB01, ,

SPAT

7.0

87.9

156

160

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

4.3

87.8

257

431

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.5

87.8

331

671

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

87.8

1658

6958

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

87.5

1172

4418

SPAT1125

SPAT

Stoma care and guidance

2.7

87.4

525

1408

SPAT1307

SPAT

Psychosocial counselling and guidance

2.3

87.3

764

2448

R1250, ,

SPAT

2.9

86.8

448

1106

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

86.6

1160

4373

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.5

86.5

334

688

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

182.4

86.4

102

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

13.7

85.9

F0029, G308,

ICD-10 Finland

+∞

85.5

P28

ICPC

Limited function/disability (P)

5.0

85.4

210

303

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

3.3

85.3

350

751

A01

ICPC

Pain general/multiple sites

1.6

84.9

2064

9266

A10AE04

ATC

insulin glargine; parenteral

1.6

84.5

2280

10502

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

84.2

8250

48137

K08.3

ICD-10 Finland

Retained dental root

1.7

84.0

1751

7550

109

Kela drug reimbursment

Multiple sclerosis

5.0

83.6

206

298

W0A10

NOMESCO Finland

Mapping of psychosocial situation

10.5

83.1

110

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

83.1

2321

10777

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

83.1

2826

13719

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.5

82.8

599

1762

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.3

82.4

240

401

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

8.2

82.4

129

113

H02AB02

ATC

dexamethasone; systemic

0.5

82.0

1060

13532

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

81.4

1138

4351

P05

ICPC

Senility, feeling/behaving old

5.1

81.2

193

270

G04BD08

ATC

solifenacin; oral

1.7

80.9

1756

7652

IGV01

NOMESCO Finland

Psychiatric network contact

6.0

80.6

163

194

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.7

80.4

284

550

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

80.1

5094

27790

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

80.1

1319

5312

Y94.0

ICD-10 Finland

Accident at home

2.6

79.9

502

1378

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.0

79.7

250

443

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.2

79.7

351

788

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

4.3

79.6

231

385

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

79.4

6382

36110

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.3

79.4

233

392

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.1

79.2

361

828

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

5.7

79.1

167

208

N05AF05

ATC

zuclopenthixol; systemic

4.1

79.1

243

424

UKC02

NOMESCO Finland

Cystoscopy

1.4

78.7

4443

23749

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.8

78.6

271

516

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.8

78.3

262

488

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.7

78.1

205

314

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

4.2

77.9

232

395

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

77.7

855

3002

S09.9

ICD-10 Finland

Unspecified injury of head

3.0

77.3

381

916

N05BA09

ATC

clobazam; oral

6.0

77.0

156

186

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.7

76.9

267

511

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

4.7

76.8

201

307

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

76.7

6091

34368

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.2

76.3

686

2223

N05BE01

ATC

buspirone; oral

2.4

76.3

603

1848

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.5

76.1

286

579

N86

ICPC

Multiple sclerosis

5.5

75.7

168

220

N06AB03

ATC

fluoxetine; oral

1.5

75.7

2358

11216

Z03

ICPC

Housing/neighbourhood problem

4.5

74.8

203

320

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.2

74.5

708

2347

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.8

74.5

408

1042

Z2446

NOMESCO Finland

Social worker

1.8

73.8

1303

5356

N06AX03

ATC

mianserin; oral

1.9

73.4

1075

4170

D12

ICPC

Constipation

2.0

73.4

927

3422

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.4

73.3

289

604

G41.9

ICD-10 Finland

Status epilepticus, unspecified

4.5

73.0

199

315

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

72.3

4911

44291

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

72.3

2943

14796

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

9.3

72.2

103

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.2

71.9

213

361

K91

ICPC

Cerebrovascular disease

2.7

71.4

415

1094

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

570.4

70.9

G04BD07

ATC

tolterodine; oral

1.8

70.9

1289

5343

P03

ICPC

Feeling depressed

1.8

70.7

1250

5138

R35

ICD-10 Finland

Polyuria

1.6

70.7

1702

7610

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

5.3

70.6

160

214

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.1

70.1

695

2344

S22.3

ICD-10 Finland

Fracture of rib

1.7

69.9

1595

7035

C07AB07

ATC

bisoprolol; oral

1.3

69.6

12887

80958

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.0

69.6

334

791

F01.39

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without information on additional symptoms

148.1

69.4

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

5.0

69.3

170

245

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.3

68.3

285

619

F06.39

ICD-10 Finland

Organic mood syndrome UNS

+∞

68.2

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

8.4

68.1

104

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

99.9

68.0

N05AC02

ATC

thioridazine; oral

2.7

66.9

402

1079

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.7

66.4

232

446

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

13.6

66.3

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.0

66.3

838

3094

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

5.7

66.0

141

178

J01MA02

ATC

ciprofloxacin; systemic

1.3

65.9

9289

56342

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.4

65.7

492

1471

N19

ICPC

Speech disorder

2.9

65.6

350

881

F07.0

ICD-10 Finland

Organic personality disorder

+∞

65.5

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.2

65.4

574

1842

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.2

65.0

635

2129

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

6.0

64.4

131

157

N80

ICPC

Head injury other

2.5

64.1

430

1220

ZY010

NOMESCO Finland

Hospital outpatient

2.0

63.7

773

2813

P76

ICPC

Depressive disorder

1.9

63.7

849

3192

N03AB02

ATC

phenytoin; systemic

2.9

63.6

323

791

M01AH05

ATC

etoricoxib; oral

0.8

63.5

9566

78234

E0000UV, ,

ATC

1.3

63.0

8589

51799

SPAT1014

SPAT

Treatment of eyes

2.4

62.9

470

1404

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

505.9

62.8

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

9.5

62.7

Z72.1

ICD-10 Finland

Alcohol use

3.2

62.2

276

623

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

62.0

8610

52019

F00, F03,

ICD-10 Finland

+∞

61.9

S01.8

ICD-10 Finland

Open wound of other parts of head

2.7

61.8

366

975

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

5.1

61.7

148

209

R40.2

ICD-10 Finland

Coma, unspecified

3.3

61.6

255

551

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.2

61.6

566

1851

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

61.6

8383

50512

ZXD05

NOMESCO Finland

Urgent procedure

1.3

61.5

6509

38002

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.4

61.5

242

506

A46

ICD-10 Finland

Erysipelas

1.4

61.2

3574

19125

SPAT1310

SPAT

Counselling related to known health issue

1.3

61.2

6911

40684

B01AC04

ATC

clopidogrel; oral

1.3

61.1

4513

25057

B01AC07

ATC

dipyridamole; systemic

1.7

61.1

1355

5927

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

61.1

6197

35975

S97

ICPC

Chronic ulcer skin

1.6

60.9

1550

7020

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

171.2

60.8

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.3

60.6

258

568

P19

ICPC

Drug abuse

4.9

60.4

150

219

OAA80, ,

SPAT

0.2

60.3

3149

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.7

60.0

208

398

Z60.8

ICD-10 Finland

Other problems related to social environment

6.6

59.9

111

120

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

5.1

59.7

142

199

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

5.2

59.7

139

191

N04BC05

ATC

pramipexole; oral

1.6

59.4

1760

8257

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

4.0

59.3

190

343

WX212

NOMESCO Finland

Femoral plexus blockade

2.1

59.2

582

1956

P18

ICPC

Medication abuse

4.9

59.1

146

212

G91.0

ICD-10 Finland

Communicating hydrocephalus

4.4

59.0

166

270

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

58.9

1805

8534

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

58.8

980

3955

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

2.4

58.5

434

1293

N18

ICPC

Paralysis/weakness

2.2

58.4

513

1646

R44.0

ICD-10 Finland

Auditory hallucinations

5.3

58.4

133

179

XF606

NOMESCO Finland

Ortostatic test

3.5

58.2

225

465

SPAT1138

SPAT

Guidance concerning bowel function

2.6

58.2

375

1044

SPAT1284

SPAT

Extensive health certificate

2.2

58.1

525

1705

N06AX12

ATC

bupropion; oral

1.9

58.0

771

2895

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

12.8

57.5

IHZ08, ,

SPAT

8.0

57.5

R60.0

ICD-10 Finland

Localized oedema

1.4

57.4

2973

15575

OAB48, ,

SPAT

0.4

57.0

310

5390

C01DA14

ATC

isosorbide mononitrate; oral

1.3

56.8

4750

26818

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

4.1

56.7

174

304

OAA67, ,

SPAT

0.4

56.6

348

5758

ZXY02

NOMESCO Finland

Neuropsychologist

5.2

56.6

131

179

N05AA01

ATC

chlorpromazine; systemic, rectal

3.0

56.6

268

630

Z08

ICPC

Social welfare problem

3.1

56.5

262

608

L03AB07

ATC

interferon beta-1a; parenteral

6.4

56.5

108

121

F31

ICD-10 Finland

Bipolar affective disorder

3.6

56.5

207

412

F23.90

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

7.9

56.4

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

55.8

596

2069

A86

ICD-10 Finland

Unspecified viral encephalitis

4.8

55.8

142

212

I95.9

ICD-10 Finland

Hypotension, unspecified

2.4

55.8

409

1212

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.7

55.7

320

839

R63.4

ICD-10 Finland

Abnormal weight loss

1.8

55.5

927

3745

F32

ICD-10 Finland

Depressive episode

1.9

55.4

735

2759

A10BB12

ATC

glimepiride; oral

1.5

55.3

1885

9115

J01DB01

ATC

cefalexin; oral

1.3

55.1

18505

122722

SPAT1127

SPAT

Enema

3.2

55.1

244

551

A04AA02

ATC

granisetron; systemic, transdermal

0.5

54.8

452

6699

R54

ICD-10 Finland

Senility

4.2

54.8

165

284

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

54.7

15899

103688

R50.9

ICD-10 Finland

Fever, unspecified

1.4

54.6

3119

16603

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

54.6

1306

5822

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.4

54.5

402

1194

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

4.6

54.5

145

225

N05BA02

ATC

chlordiazepoxide; systemic

2.2

54.5

525

1751

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

54.2

1118

4794

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.8

53.9

299

770

AA1CG, ,

SPAT

3.5

53.4

206

425

P16

ICPC

Acute alcohol abuse

2.8

53.4

285

718

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3.4

53.4

210

439

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.7

53.3

324

876

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.8

53.1

296

764

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

11.0

53.1

EBA30

NOMESCO Finland

Extraction of root of tooth

1.6

53.0

1220

5385

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

52.5

11313

71350

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.7

52.4

1085

4657

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

52.3

523

1770

AA1AD, ,

SPAT

6.2

52.3

102

117

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.5

52.3

2017

9999

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3.7

52.2

182

350

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

52.2

6810

40637

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.4

52.1

395

1189

F0011, G301,

ICD-10 Finland

419.9

52.0

N04BC09

ATC

rotigotine; transdermal

4.4

51.8

144

232

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

5.0

51.8

125

178

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

4.6

51.4

137

213

N06AA09

ATC

amitriptyline; systemic

1.5

51.4

2080

10407

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

51.3

4590

26108

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

4.9

50.8

125

181

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

50.8

1708

8230

L75

ICPC

Fracture: femur

2.5

50.6

357

1039

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.7

50.3

1085

4708

N05BA12

ATC

alprazolam; oral

1.5

50.3

1901

9382

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.0

50.3

562

1985

EBA00

NOMESCO Finland

Extraction of tooth

1.3

50.2

6830

40913

IGP01

NOMESCO Finland

Psychiatric family contact

5.5

50.1

110

143

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

49.9

3852

21452

F02.30

ICD-10 Finland

Dementia in Parkinson's disease without additional symptoms

108.8

49.9

K92.0

ICD-10 Finland

Haematemesis

2.0

49.8

583

2095

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

3.0

49.7

245

590

P98

ICPC

Psychosis NOS/other

4.6

49.7

131

202

R45.1

ICD-10 Finland

Restlessness and agitation

7.2

49.5

C07AB02

ATC

metoprolol; systemic

1.3

49.4

5374

31326

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

3.5

49.3

190

392

Z00.0

ICD-10 Finland

General medical examination

1.3

49.3

4089

23002

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.9

49.2

159

289

N06AA12

ATC

doxepin; systemic

1.6

49.1

1164

5174

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

4.5

49.0

134

213

C09AA05

ATC

ramipril; oral

1.3

49.0

6533

39020

N06AX05

ATC

trazodone; oral

2.2

48.8

433

1396

M03BX01

ATC

baclofen; systemic

2.4

48.7

366

1097

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.0

48.7

548

1940

S28

ICPC

Limited function/disability (S)

3.4

48.6

194

410

L03AX13

ATC

glatiramer acetate; parenteral

7.1

48.5

GD1AA, ,

SPAT

0.5

48.5

540

7252

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

6.6

48.4

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

48.3

1546

7369

F61.0

ICD-10 Finland

Mixed personality disorders

3.0

48.2

234

559

R51.80

ICD-10 Finland

Headache

1.4

48.1

2509

13136

XKD00

NOMESCO Finland

Uroflowmetry

1.3

47.7

4268

24243

N04BB01

ATC

amantadine; oral

2.4

47.5

350

1040

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.4

47.5

280

4713

S20.2

ICD-10 Finland

Contusion of thorax

1.7

47.4

1014

4389

OAA65, ,

SPAT

0.4

47.3

338

5279

SPAT1281

SPAT

Other administrative function

1.5

47.1

1600

7722

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

47.1

2050

10391

R45.5

ICD-10 Finland

Hostility

22.4

47.1

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

6.6

47.1

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

46.9

6385

38192

N03AX16

ATC

[U] pregabalin

1.3

46.8

4904

28425

N03AX11

ATC

topiramate; oral

2.5

46.8

320

918

HA1RA, ,

SPAT

0.3

46.7

119

2985

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

46.4

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.8

46.3

692

2701

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

46.3

1057

4655

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

5.4

46.2

103

136

SPAT1243

SPAT

Psychiatric/psychological examination

2.5

46.1

305

861

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

45.8

1758

8696

SPAT1285

SPAT

Provision of consultation response

1.6

45.7

1139

5126

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

45.7

1228

5627

F34.1

ICD-10 Finland

Dysthymia

2.0

45.5

524

1871

SPAT1244

SPAT

Occupational therapy

2.8

45.5

255

661

L76

ICPC

Fracture: other

1.8

45.4

682

2665

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

7.7

45.2

SPAT1325

SPAT

Vaccination

1.2

45.1

8224

50717

E87.6

ICD-10 Finland

Hypokalaemia

1.8

45.0

757

3064

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

44.9

9433

59007

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

44.8

881

3728

R4150

NOMESCO Finland

Neuropsychological rehabilitation

4.1

44.8

137

239

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

44.8

4649

26896

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

362.6

44.7

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

44.5

4648

26906

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

5.9

44.5

110

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.3

44.3

361

1123

A10BH05

ATC

linagliptin; oral

1.5

44.3

1303

6096

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

7.1

43.9

P27

ICPC

Fear of mental disorder

3.2

43.8

187

413

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

43.6

3738

21087

A10AE05

ATC

insulin detemir; parenteral

1.6

43.5

1077

4837

LAITO, ,

NOMESCO Finland

13.0

43.5

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

2.3

43.4

367

1160

D21

ICPC

Swallowing problem

2.3

43.4

366

1156

SPAT1255

SPAT

Intravenous administration of medicine

1.5

43.3

1472

7103

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.8

43.0

3056

27741

F06.33

ICD-10 Finland

Organic mood syndrome

348.3

42.9

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

6.6

42.9

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.6

42.9

1037

4631

L01BC06

ATC

capecitabine; oral

0.4

42.9

238

4106

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

42.8

2089

10800

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.7

42.8

857

3644

AA400

NOMESCO Finland

Electroconvulsive therapy

3.7

42.8

150

290

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

+∞

42.8

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

4.7

42.6

109

164

G04BD09

ATC

trospium; oral

1.9

42.3

594

2272

Z51.5

ICD-10 Finland

Palliative care

1.4

42.3

2016

10380

G04CB02

ATC

dutasteride; oral

1.4

42.2

2057

10631

P01

ICPC

Feeling anxious/nervous/tense

1.6

42.2

1183

5474

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.7

42.1

820

3460

K92.1

ICD-10 Finland

Melaena

1.5

42.1

1316

6238

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

10.6

42.0

NF3AA

NOMESCO Finland

Femur X-ray examination

2.0

41.9

489

1755

A99

ICPC

Disease/condition unspecnature/site

1.4

41.9

1955

10029

G40.89

ICD-10 Finland

Other epilepsy

4.3

41.8

121

202

AA1AA

NOMESCO Finland

Head X-ray examination

2.9

41.8

210

512

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

4.4

41.8

117

190

F06.31

ICD-10 Finland

Organic bipolar syndrome

56.1

41.7

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

4.9

41.6

104

153

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.8

41.5

722

2951

SPAT1104

SPAT

Monitoring of emergency patient

1.5

41.5

1434

6943

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

2.6

41.4

254

691

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

41.2

4057

23284

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.4

40.9

270

4349

XF606, ,

SPAT

3.5

40.9

158

327

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.2

40.8

392

1307

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

40.7

967

4300

F02.32

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly hallucinations

171.1

40.7

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.2

40.6

356

1143

XA400

NOMESCO Finland

EEG

3.5

40.6

152

308

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

40.6

2501

23189

T68

ICD-10 Finland

Hypothermia

3.7

40.5

139

265

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.4

40.5

157

326

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

40.5

852

3673

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

5.3

40.4

124

U28

ICPC

Limited function/disability (U)

2.5

40.4

280

809

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.8

40.4

3120

28035

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.5

40.4

1361

6554

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

4.6

40.4

107

166

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

4.2

40.3

118

199

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

7.3

40.2

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

326.8

40.2

Z72.2

ICD-10 Finland

Drug use

5.3

40.2

122

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

2.7

40.2

232

611

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.1

40.2

412

1409

N06AB05

ATC

paroxetine; oral

1.6

40.1

928

4100

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

3.1

40.0

187

437

N07AA05, ,

ATC

+∞

40.0

N05AL01

ATC

sulpiride; systemic

2.4

40.0

309

939

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.5

39.9

262

737

F23.91

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

8.2

39.9

F002, G308,

ICD-10 Finland

167.5

39.8

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

39.5

2473

13313

N03AX12

ATC

[U] gabapentin; oral

1.3

39.5

3291

18471

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

319.7

39.3

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

6.8

39.2

R01AD58

ATC

fluticasone, combinations; nasal

0.7

39.2

2127

20110

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.8

39.2

2712

24744

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

+∞

39.1

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.4

39.1

2076

10883

E000001, ,

ATC

1.3

39.1

3695

21084

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.2

38.9

336

1073

S32.5

ICD-10 Finland

Fracture of pubis

2.6

38.8

235

635

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.4

38.8

285

847

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.5

38.7

306

4608

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.9

38.6

489

1807

Z43.5

ICD-10 Finland

Attention to cystostomy

3.0

38.6

186

443

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.8

38.5

570

2218

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

4.4

38.5

108

176

ZXD35

NOMESCO Finland

Usual procedure

1.8

38.4

677

2778

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

3.3

38.3

157

338

SPAT1265

SPAT

Breathalyser

3.2

38.3

163

360

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

2.8

38.1

211

544

OAB95, ,

SPAT

0.3

38.0

2303

F10.59

ICD-10 Finland

Alcohol psychosis, mixed type

10.5

37.9

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

37.9

430

5748

-2, ,

ICPC

3.4

37.9

150

316

U05

ICPC

Urination problems other

1.5

37.8

1186

5623

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.6

37.8

916

4092

Z10.0

ICD-10 Finland

Occupational health examination

0.4

37.8

162

3126

N07

ICPC

Convulsion/seizure

6.1

37.6

F01.23

ICD-10 Finland

Subcortical vascular dementia other additional symptoms, mainly depression

41.2

37.6

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

4.2

37.5

112

192

F30.9

ICD-10 Finland

Manic episode, unspecified

5.4

37.5

109

G93.4

ICD-10 Finland

Encephalopathy, unspecified

5.2

37.5

117

U08

ICPC

Urinary retention

1.9

37.4

511

1937

U13

ICPC

Bladder symptom/complaint other

1.8

37.4

629

2547

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

3.5

37.3

142

291

Z11

ICPC

Compliance/being ill problem

3.2

37.2

164

370

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

3.3

37.0

152

328

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.6

36.7

866

3845

F06.6

ICD-10 Finland

Organic emotionally labile [asthenic] disorder

298.2

36.6

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.6

36.5

233

647

164

Kela drug reimbursment

Fingolimod

9.3

36.5

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.6

36.2

846

3747

A41.9

ICD-10 Finland

Sepsis, unspecified

1.6

36.1

852

3782

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

5.9

36.0

N06AG02

ATC

moclobemide; oral

1.6

35.9

832

3676

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

4.4

35.9

159

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.6

35.8

132

265

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

2.1

35.7

371

1276

RT250, ,

NOMESCO Finland

7.4

35.6

XF600, ,

SPAT

1.8

35.6

592

2389

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

35.5

2128

11373

C08CA01

ATC

amlodipine; oral

1.2

35.4

9635

61315

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.8

35.1

133

Angiography of the heart and coronary arteries

1.4

34.9

1701

8783

WYA20, ,

SPAT

3.5

34.7

133

274

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

9.1

34.7

T74.1

ICD-10 Finland

Physical abuse

2.7

34.7

201

531

Z3231

NOMESCO Finland

Registered nurse

1.2

34.7

5925

36090

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

34.6

1315

6485

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

4.8

34.6

129

Z3226

NOMESCO Finland

Physiotherapist

1.3

34.6

3729

21597

R31

ICD-10 Finland

Unspecified haematuria

1.3

34.5

2557

14098

A05

ICPC

Feeling ill

1.6

34.5

837

3740

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

5.9

34.5

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.4

34.5

265

804

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.9

34.4

466

1763

B01AF02

ATC

apixaban; oral

1.3

34.2

3266

18632

A10BA02

ATC

metformin; oral

1.2

34.2

6768

41808

RT150, ,

NOMESCO Finland

8.4

34.2

F02.80

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without additional symptoms

62.7

34.0

SPAT1097

SPAT

Recording of ECG

1.3

34.0

3404

19533

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

34.0

1684

8720

F23.8

ICD-10 Finland

Other acute and transient psychotic disorders

6.8

33.9

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.6

33.8

829

3714

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

4.7

33.7

135

R47.0

ICD-10 Finland

Dysphasia and aphasia

2.4

33.6

254

765

EB4VA, ,

NOMESCO Finland

0.6

33.6

644

7462

S01

ICD-10 Finland

Open wound of head

2.3

33.5

261

797

ZYY02

NOMESCO Finland

Contact between professionals and family members

14.6

33.5

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

33.2

827

3719

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

4.9

33.2

117

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.7

33.1

197

528

P71

ICPC

Organic psychosis other

17.3

33.1

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.9

33.0

469

1802

C07AA05

ATC

propranolol; systemic

1.3

33.0

3317

19038

S42.0

ICD-10 Finland

Fracture of clavicle

1.8

32.9

502

1974

A10AC01

ATC

insulin (human); parenteral

1.4

32.8

1588

8189

N05CD08

ATC

midazolam; nasal, systemic

1.8

32.7

511

2024

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

32.7

2330

12772

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.7

32.6

710

3088

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.0

32.6

396

1444

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.6

32.6

120

241

IEY01

NOMESCO Finland

Psychoeducation, individual

4.4

32.6

145

Y94.1

ICD-10 Finland

Accident in connection with service housing

9.7

32.6

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.8

32.5

502

1981

353

Kela drug reimbursment

Cladribine and fingolimod

9.4

32.5

IEV99

NOMESCO Finland

Other psychiatric network intervention

5.7

32.5

D07AA02

ATC

hydrocortisone; topical

1.3

32.4

2355

12945

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

32.3

6284

38709

F32.8

ICD-10 Finland

Other depressive episodes

2.5

32.2

216

615

A02BC01

ATC

omeprazole; systemic

1.2

32.2

6099

37478

SDA03

NOMESCO Finland

Periodontal treatment

0.8

32.1

5256

43559

F0024, G308,

ICD-10 Finland

262.4

32.1

F02.09

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

262.4

32.1

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

262.4

32.1

T08

ICPC

Weight loss

2.1

32.1

332

1141

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

12.1

32.1

R4120

NOMESCO Finland

Occupational therapy

1.5

32.0

1204

5925

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

32.0

1814

9604

R4130

NOMESCO Finland

Speech therapy

1.8

32.0

499

1976

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.6

31.9

785

3521

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.2

31.9

283

915

F02.89*E03.9

ICD-10 Finland

Dementia in hypothyroidism, acquired

+∞

31.8

2930A

ICD-9 Finland

Transient organic psychotic conditions, Acute delirium

+∞

31.8

A10AD05

ATC

insulin aspart; parenteral

1.9

31.8

452

1737

U07

ICPC

Urine symptom/complaint other

1.4

31.8

1585

8212

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.5

31.8

229

3568

F21

ICD-10 Finland

Schizotypal disorder

4.0

31.8

100

179

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.6

31.7

574

6748

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

4.1

31.7

170

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

4.6

31.6

131

WX892

NOMESCO Finland

Monitored bed care

1.4

31.6

1656

8654

S01.3

ICD-10 Finland

Open wound of ear

2.3

31.6

255

792

A03FA01

ATC

metoclopramide; systemic, rectal

0.8

31.5

3184

27781

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

10.3

31.5

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

4.8

31.5

117

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

4.7

31.4

123

SPAT1227

SPAT

Substance abuse rehabilitation

3.6

31.3

114

227

F30.0

ICD-10 Finland

Hypomania

5.7

31.2

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

2.2

31.1

294

975

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

30.9

2779

15716

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.4

30.8

232

698

E51.2

ICD-10 Finland

Wernicke encephalopathy

7.9

30.8

NG1AA, ,

SPAT

0.5

30.8

234

3575

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

5.8

30.8

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

30.8

9618

61689

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

8.9

30.7

ZYY79

NOMESCO Finland

Other indirect service without contact with patient

8.6

30.7

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.6

30.7

197

549

N05AB01

ATC

dixyrazine; systemic

2.3

30.6

250

780

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.7

30.6

948

9899

L03AB08

ATC

interferon beta-1b; parenteral

7.3

30.6

F05

ICD-10 Finland

Delirium, not induced by alcohol and other psychoactive substances

12.8

30.5

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.5

30.5

259

3804

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.4

30.5

1549

8051

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

30.4

5471

33416

A10BH01

ATC

sitagliptin; oral

1.3

30.3

2130

11646

N05AE04

ATC

ziprasidone; systemic

4.4

30.2

139

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.5

30.1

275

3941

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

30.1

6574

40881

F009, F03,

ICD-10 Finland

+∞

30.0

R01AD12

ATC

fluticasone furoate; nasal

0.8

30.0

3323

28707

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

3.7

29.9

105

204

ZYD01

NOMESCO Finland

Emergency clinic

6.8

29.9

P74

ICPC

Anxiety disorder/anxiety state

1.8

29.9

438

1701

J01FA10

ATC

azithromycin; systemic

0.9

29.8

8456

66884

IBB01

NOMESCO Finland

Psychiatric functioning capacity evaluation

6.9

29.8

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4613

18356

1.96

314.08

1.9

1.8

—

(3023410) Appearance of Cerebral spinal fluid

719

981

5.34

310.53

1.3

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4584

18314

1.95

307.84

2.0

1.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

14619

66001

2.34

307.65

2.4

2.0

91.82

94.40

pmol/l

8.12

7928

33665

(3024561) Albumin [Mass/volume] in Serum or Plasma

13705

68505

1.91

307.65

4.4

4.9

34.58

34.69

g/l

1.31

12454

63215

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10097

48406

1.80

307.65

2.6

2.1

275.28

211.23

u/l

7.22

9479

44918

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

14405

72975

1.92

307.65

6.2

1.21

mmol/l

4.82

12950

65782

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1785

2593

5.19

307.65

1.2

1.3

514.38

577.44

mg/l

2.22

1664

2477

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

11762

58651

1.79

307.65

2.3

2.2

76.66

80.09

nmol/l

27.47

10141

51035

(3021960) Folate [Moles/volume] in Serum or Plasma

10624

37137

2.77

307.65

1.7

1.6

20.23

20.38

nmol/l

0.35

9139

31064

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7377

29217

2.12

307.65

2.8

3.3

2.46

mmol/l

6.55

6520

25266

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6527

26767

1.99

307.65

2.0

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

17539

99862

1.79

307.65

6.3

4.8

2843.05

1089.20

e6/l

3.05

386

1411

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1338

440

22.77

307.65

1.0

649.74

838.00

ng/l

12.81

950

262

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1325

443

22.39

307.65

1.0

360.90

258.68

ng/l

5.61

968

278

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1339

444

22.59

307.65

1.0

47.66

31.53

ng/l

20.69

963

269

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1613

2218

5.45

307.65

1.3

1.4

12.67

35.87

e6/l

2.04

1227

1718

(3015377) Calcium [Moles/volume] in Serum or Plasma

11369

51773

2.01

307.65

2.8

3.5

2.35

mmol/l

0.92

9748

44289

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8143

33055

2.10

307.65

1.8

1.7

10796852.55

33383134.88

pmol/l

4.95

6567

26334

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

15834

80026

2.07

307.65

6.7

6.9

1.22

1.21

mmol/l

14.89

13300

67388

(3026008) Bacteria identified in Urine by Culture

10692

50113

1.89

307.65

4.0

3.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

9873

30886

3.07

307.65

1.9

1.7

1185.70

1144.56

nmol/l

3.80

7448

22627

(3023368) Bacteria identified in Blood by Culture

9761

45741

1.84

307.65

4.6

4.4

—

(3018418) pH of Serum or Plasma

9908

47271

1.80

307.65

3.7

4.3

7.40

0.48

1752

9060

(3044290) Cell count panel - Cerebral spinal fluid

1405

2151

4.86

307.65

1.2

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1616

2254

5.38

307.65

1.2

1.3

3.91

3.82

mmol/l

1.67

1516

2115

(3009466) Valproate [Moles/volume] in Serum or Plasma

1186

1341

6.55

307.65

4.9

4.6

357.16

353.96

umol/l

0.25

1016

1129

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1615

2220

5.46

307.65

1.3

1.4

678.58

2396.95

e6/l

1.04

1294

1814

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

11599

61695

1.62

280.57

4.9

4.0

69.79

75.16

ng/l

0.11

9449

47123

(3023183) Ammonium ion [Moles/volume] in Plasma

1287

2995

3.17

277.62

2.4

28.95

34.28

umol/l

11.50

1105

2664

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8288

40652

1.67

275.15

2.4

2.3

3.04

3.09

mg/l

0.82

6903

34407

(3013826) Glucose [Moles/volume] in Serum or Plasma

15687

91163

1.58

247.13

5.9

4.8

7.00

6.84

mmol/l

11.84

14925

85776

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2556

9204

2.08

223.34

1.6

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

13846

79303

1.53

220.50

20.0

18.3

1.34

1.36

inr

0.76

3730

22302

(3016018) Differential panel - Cerebral spinal fluid

671

1164

4.19

219.82

1.3

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

17183

104792

1.51

185.98

4.1

4.0

15.15

15.06

pmol/l

4.54

15189

92938

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2849

11516

1.86

176.32

2.1

1.7

1.69

1.55

11.54

2394

9649

(3037467) Urinalysis macro (dipstick) panel - Urine

16849

102929

1.48

174.07

5.5

4.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2586

10183

1.90

173.30

1.8

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

594

1157

3.72

166.71

1.3

1.5

—

(3019150) Specific gravity of Urine by Refractometry

6134

31066

1.53

159.50

5.4

4.4

1.02

kg/l

0.39

971

4931

(3028707) Methadone [Presence] in Urine by Screen method

463

777

4.30

157.93

4.1

2.6

—

(3035350) Ketones [Presence] in Urine by Test strip

12219

71457

1.41

147.70

4.9

4.0

0.00

estimate

0.53

2450

14607

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

341

464

5.29

147.46

1.2

1.3

51.00

61.13

0.53

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1607

5732

2.06

141.46

2.3

755.57

515.42

ug/l

1.00

1510

5422

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

20043

128667

1.50

141.25

5.4

4.9

2.01

2.15

mu/l

2.82

18032

114926

(3015736) pH of Urine

10064

57256

1.41

139.45

4.5

3.7

5.82

0.01

219

2474

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

302

387

5.61

138.81

18.6

17.0

1325.70

1429.14

nmol/l

1.14

290

372

(3009261) Glucose [Presence] in Urine by Test strip

12257

72321

1.39

136.22

4.9

4.0

0.00

estimate

2.19

2169

13228

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

18353

116175

1.44

134.69

7.2

8.0

80.41

80.71

u/l

0.29

17052

108958

(3036180) Methadone [Presence] in Urine

234

239

7.02

132.24

3.1

2.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

2909

12864

1.69

129.85

3.3

3.2

4.43

4.50

kpa

0.85

2801

12435

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

284

369

5.53

128.76

13.4

12.2

742.69

845.12

nmol/l

2.30

272

344

(3021601) Nitrite [Presence] in Urine by Test strip

12070

71464

1.38

128.28

6.4

5.3

0.00

estimate

1.08

2214

13565

(3012544) pH of Venous blood

3518

16399

1.61

127.63

3.7

3.9

7.39

7.38

0.28

121

(3002032) Base excess in Venous blood by calculation

3406

15783

1.62

126.50

3.8

3.9

2.03

1.89

mmol/l

1.28

2925

13361

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3409

15817

1.62

125.91

3.7

3.9

5.82

5.83

kpa

0.18

3300

15371

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

8576

48383

1.39

119.21

2.7

2.6

68.74

61.44

u/l

0.34

7881

44307

(3002582) Erythrocytes [#/volume] in Urine

8699

49363

1.38

115.89

3.9

3.4

112.06

108.37

e6/l

0.06

6824

38172

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

9347

53746

1.37

114.42

5.4

4.3

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

278

398

5.01

113.95

14.6

11.6

0.67

0.63

mmol/l

1.17

254

358

(3026782) Osmolality of Urine

6193

33368

1.42

110.36

3.4

3.0

536.95

540.20

mosm/kgh2o

0.55

5327

28535

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2653

11942

1.65

109.47

1.8

1.6

—

(3018095) Leukocytes [#/volume] in Urine

9637

56069

1.36

107.45

4.5

3.9

136.69

114.71

e6/l

1.05

7182

40649

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1308

4810

1.99

105.18

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2407

10681

1.67

104.68

7.4

7.1

24.59

24.61

mmol/l

0.09

2318

10162

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

13256

81135

1.34

104.24

5.3

6.4

11.79

12.09

umol/l

1.70

12378

77041

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

344

649

3.81

100.88

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

420

910

3.32

100.80

1.2

1.3

2.08

2.28

mmol/l

2.16

386

839

(3013707) Erythrocyte sedimentation rate by Westergren method

16950

107878

1.35

100.31

4.3

14.92

14.17

mm/h

6.81

15339

98387

(3029937) Albumin [Presence] in Urine by Test strip

7028

39225

1.38

99.96

5.4

4.4

0.00

estimate

3.67

2058

12884

(3003396) Base excess in Arterial blood by calculation

3957

19919

1.49

99.27

7.1

6.8

1.38

1.07

mmol/l

4.68

3116

15945

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

338

638

3.81

99.06

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

4891

25690

1.44

98.44

1.9

2.0

29.65

30.11

5.52

4719

24953

(1001926) Buprenorphine [Presence] in Urine by Screen method

525

1322

2.86

98.21

4.0

2.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3198

15458

1.54

96.99

2.7

2.4

5.38

7.08

ug/l

8.01

2503

13464

(3027801) Oxygen [Partial pressure] in Arterial blood

3933

19952

1.48

94.45

7.1

6.8

11.55

12.05

kpa

7.64

3749

18963

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3935

19968

1.48

94.35

7.1

6.8

5.04

5.09

kpa

2.27

3756

18985

(3011288) Drugs identified in Urine by Screen method

462

1112

2.99

93.51

5.9

2.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

394

871

3.25

91.67

1.8

1.3

1.18

1.25

promille

0.34

305

666

(36304419) Bacteria [Presence] in Urine

7617

43582

1.35

90.42

3.8

3.3

—

(21494755) Public health laboratory ask at order entry panel

223

5678

0.27

90.32

1.2

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

7926

45633

1.34

90.22

3.8

3.3

0.52

0.46

e6/l

1.42

6224

35136

(3000850) Epithelial cells [#/volume] in Urine

6265

34794

1.37

89.96

3.0

2.7

5.64

4.90

e6/l

5.08

5655

31040

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

5892

32409

1.38

89.72

4.5

4.0

209.55

505.95

ng/l

11.50

5160

27510

(3016502) Oxygen saturation in Arterial blood

3554

17841

1.48

89.47

7.4

7.1

95.29

95.41

0.50

3423

17164

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

405

949

3.07

85.78

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

218

326

4.79

85.26

1.2

1.3

32.38

20.83

0.54

(3001122) Ferritin [Mass/volume] in Serum or Plasma

9707

57911

1.31

84.55

3.0

2.9

148.13

160.22

ug/l

3.53

8566

52423

(40768804) Tissue Pathology biopsy report

7021

61065

0.75

83.54

2.1

2.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

3938

20413

1.44

83.43

2.1

2.4

1.78

0.16

3309

17967

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

358

6878

0.36

83.19

1.6

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9069

53690

1.31

83.12

3.1

3.2

1910.79

1694.39

ng/l

3.28

7772

46689

(1761868) Lipid panel - Serum or Plasma

4362

40759

0.71

82.95

3.5

3.3

—

(3019060) Gas panel - Arterial blood

2473

11697

1.56

81.70

5.2

4.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2221

10264

1.59

81.05

3.6

3.4

127.00

127.26

g/l

0.21

2171

10003

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3235

16230

1.48

80.98

7.8

7.5

120.04

120.25

g/l

0.23

3156

15793

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

200

291

4.92

80.65

2.6

2.4

147.75

139.24

nmol/l

0.37

174

251

(3016879) Cocaine [Presence] in Urine

554

1597

2.50

79.93

4.0

2.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

11076

67982

1.28

74.28

2.6

2.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2973

14916

1.47

73.89

6.5

6.4

1.47

1.36

mmol/l

5.08

2893

14466

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1766

7890

1.64

73.69

3.0

2.8

1.25

1.19

1.63

1757

7848

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

21146

141298

1.37

73.17

22.4

16.7

28.34

26.32

mg/l

13.63

18237

114685

(3011397) Hemoglobin [Presence] in Urine by Test strip

6164

35046

1.33

73.01

4.7

3.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2739

13551

1.49

72.92

3.8

4.0

1.23

mmol/l

1.41

2295

11789

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1735

7752

1.64

72.33

4.3

4.2

47.03

47.20

0.10

1715

7664

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4829

26542

1.36

71.29

2.9

3.2

0.81

mmol/l

4.77

4377

24649

(3000764) Benzodiazepines [Presence] in Urine

557

1706

2.35

70.57

4.0

2.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2518

12325

1.50

70.46

1.9

2.3

388.15

378.96

nmol/l

1.29

2250

11284

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1716

7734

1.62

69.00

3.0

2.7

0.67

0.65

1.53

1709

7701

(3014576) Chloride [Moles/volume] in Serum or Plasma

4010

21486

1.39

69.00

6.8

6.7

104.14

104.32

mmol/l

1.24

4005

21469

(3028300) Cannabinoids [Presence] in Urine

556

1725

2.32

68.44

4.1

2.1

—

(3027008) Opiates [Presence] in Urine

554

1720

2.32

68.08

4.0

1.9

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4077

21953

1.38

67.98

4.9

5.7

1.02

1.04

mmol/l

4.06

3701

20247

(3027273) Bicarbonate [Moles/volume] in Venous blood

1833

8431

1.59

67.73

3.7

3.6

25.27

25.16

mmol/l

0.61

1779

8208

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1591

7130

1.63

65.35

5.6

5.0

1.70

1.60

2.13

1512

6692

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

194

4461

0.30

64.81

1.4

1.5

—

(3014271) Vancomycin [Susceptibility]

376

991

2.72

64.78

3.2

2.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

242

495

3.50

63.47

2.3

1.7

107.23

109.31

umol/l

0.04

122

267

(3027944) Amphetamines [Presence] in Urine

532

1675

2.29

63.33

4.0

2.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

289

664

3.12

63.33

1.4

1.5

—

(3003181) Sodium [Moles/volume] in Urine

818

3050

1.94

62.84

1.4

1.3

62.47

61.69

mmol/l

0.21

650

2447

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

306

734

2.99

62.41

2.5

2.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

245

512

3.43

62.26

2.6

2.2

57.50

52.06

umol/l

1.47

195

423

(3007930) Methemoglobin/Hemoglobin.total in Blood

1560

7045

1.61

62.03

5.6

5.1

0.90

0.88

1.40

1486

6601

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

222

443

3.59

60.37

3.2

2.7

29.14

28.75

umol/l

0.17

152

342

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1450

6483

1.63

59.99

1.9

1.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4684

26329

1.33

57.89

3.5

3.1

3.09

2.40

e6/l

3.20

2569

14656

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1675

7828

1.56

57.49

3.9

4.1

24.34

24.09

mmol/l

2.26

1623

7640

(3018405) Lactate [Moles/volume] in Arterial blood

1349

5990

1.64

57.31

4.4

4.2

1.41

1.38

mmol/l

0.34

1332

5878

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5000

28408

1.31

57.16

3.3

2.9

1.45

1.26

e6/l

1.02

2859

16611

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1531

7035

1.58

56.50

2.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

1180

5101

1.68

55.56

4.6

4.5

3.89

3.91

mmol/l

0.57

1171

5055

(40761535) Cells panel - Urine sediment

2624

13536

1.42

55.19

4.0

3.6

—

(3047181) Lactate [Moles/volume] in Blood

1195

5194

1.67

55.12

6.5

6.0

1.40

1.32

mmol/l

1.33

1080

4598

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

171

307

3.98

53.78

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

3344

18098

1.36

52.69

1.9

1.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

13191

84670

1.22

50.93

3.8

3.1

55.03

55.32

u/l

0.11

11869

76904

(3006270) Folate [Moles/volume] in Blood

401

1235

2.33

50.27

1.3

1.2

319.14

325.20

nmol/l

0.21

319

960

(3008295) Osmolality of Serum or Plasma

464

1534

2.17

49.23

1.5

1.3

276.84

277.11

mosm/kgh2o

0.07

344

1167

(3023520) Reticulocytes [#/volume] in Blood

2914

15586

1.37

49.18

2.2

2.6

67.33

68.61

e9/l

1.06

2211

11917

(3022948) Iron [Moles/volume] in Serum or Plasma

4616

26472

1.29

48.07

2.4

2.6

11.41

12.29

umol/l

12.18

4104

24540

(3020891) Body temperature

1440

6783

1.54

47.49

5.3

4.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

6134

36487

1.26

47.35

4.6

3.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1440

15035

0.66

47.32

1.4

—

(3019225) pH of Specimen

3142

17105

1.35

47.24

4.3

4.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2436

12728

1.40

47.21

3.2

3.9

90.85

97.27

ng/l

2.81

1972

10790

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

373

1145

2.34

47.13

1.4

1.8

1857.78

1394.78

titre

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2940

15859

1.36

46.88

3.1

3.0

234.14

241.87

ng/l

0.33

2697

14573

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1518

7329

1.50

44.58

2.0

1.9

2.51

2.16

ug/l

0.42

1236

6484

(3000991) Gas panel - Venous blood

2672

14353

1.36

43.55

7.6

7.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

161

325

3.54

43.21

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

21827

148864

1.29

42.45

27.0

19.9

139.49

139.58

mmol/l

4.36

21272

144967

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2760

14957

1.35

42.43

2.1

2.2

0.20

g/l

3.93

2447

13858

(3039000) Anion gap in Blood

865

3709

1.68

41.91

7.3

6.9

11.34

11.24

mmol/l

0.31

800

3326

(3018572) Chloride [Moles/volume] in Blood

865

3710

1.68

41.87

7.3

6.9

104.80

104.87

mmol/l

0.13

800

3327

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

160

329

3.48

41.81

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

158

325

3.47

41.28

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4269

24727

1.27

40.18

2.4

2.6

2.23

2.28

g/l

5.58

3784

22784

(3023103) Potassium [Moles/volume] in Serum or Plasma

21835

149121

1.28

40.13

27.0

20.1

3.99

4.00

mmol/l

1.62

21254

144986

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

468

6196

0.53

39.98

1.2

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2103

11015

1.39

39.86

3.5

3.8

5.19

5.15

kpa

1.21

1921

10440

(3009343) pH of Capillary blood

2080

10883

1.39

39.66

3.5

3.8

7.42

0.58

302

1417

(44816559) Phosphatidylethanol [Mass/volume] in Blood

515

1920

1.93

39.63

1.6

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2015

10508

1.40

39.16

3.4

3.7

2.02

1.87

mmol/l

0.90

1462

7900

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

154

323

3.41

39.11

1.1

—

(4035726) Immunohistochemistry procedure

1479

14846

0.69

39.05

1.3

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

148

306

3.46

38.41

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

507

1906

1.91

38.08

20.0

7.4

7.72

7.33

mmol/l

1.31

410

1578

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3581

20429

1.29

37.81

10.5

7.8

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

130

4.99

37.65

2.0

1.9

20.66

16.79

umol/l

1.82

130

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7236

44712

1.21

37.09

3.3

36.09

35.68

u/l

0.14

6739

42008

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

837

3694

1.63

36.29

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

837

3694

1.63

36.29

1.4

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

201

523

2.75

35.70

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2999

16906

1.30

34.44

4.7

3.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

250

746

2.40

33.77

1.2

1.1

39.81

47.27

mg/l

2.11

202

632

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3997

23430

1.25

33.30

2.5

2.7

20.81

21.72

3.26

3124

19971

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

239

708

2.42

32.82

1.1

269.05

326.63

mg/l

3.97

202

620

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2340

21314

0.76

32.80

1.2

14.27

15.20

u/ml

0.21

736

7290

(3020779) Urea [Moles/volume] in Serum or Plasma

2788

15738

1.29

31.50

5.8

6.8

10.51

11.07

mmol/l

3.47

2584

14848

(3002256) Pathology report gross observation

2296

20851

0.76

31.35

1.3

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2016

10915

1.34

30.69

8.8

8.2

1.45

1.33

5.18

2002

10836

(3019832) Treponema pallidum Ab [Presence] in Serum

1002

4800

1.51

30.43

1.4

1.6

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2007

10893

1.34

30.03

8.8

8.3

0.69

0.66

2.56

1992

10821

(3015235) Bicarbonate [Moles/volume] in Capillary blood

948

4523

1.51

29.35

2.8

3.2

24.87

24.86

mmol/l

0.02

923

4441

(3022621) pH of Urine by Test strip

1856

10021

1.34

28.73

3.9

3.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2278

12694

1.30

28.22

2.1

2.5

—

(3028271) Lactate [Moles/volume] in Capillary blood

626

2744

1.64

27.94

2.2

1.9

1.82

1.71

mmol/l

1.48

614

2684

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

182

3.72

27.62

1.1

1.3

29.41

52.16

3.40

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

18484

137331

0.85

27.44

4.6

4.8

1.43

1.45

mmol/l

3.60

16289

123368

(3016038) Potassium [Moles/volume] in Urine

312

1113

2.01

27.37

1.1

32.38

35.02

mmol/l

1.17

255

933

(3010421) pH of Blood

922

4448

1.49

27.07

4.3

4.2

7.42

1.47

808

4063

(3019198) Lymphocytes [#/volume] in Blood

11507

75319

1.16

27.04

6.0

5.8

1.80

1.90

e9/l

3.94

9921

65520

(3020630) Protein [Mass/volume] in Serum or Plasma

2665

15239

1.27

26.94

2.2

2.6

65.76

66.15

g/l

1.69

2284

13728

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2583

22705

0.79

26.80

1.2

1.3

41.57

40.00

iu/ml

0.18

785

7024

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

17840

132815

0.85

26.46

4.1

4.3

1.27

1.28

mmol/l

1.79

15534

118060

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1729

9351

1.34

26.41

9.5

9.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1628

8729

1.35

26.33

3.1

2.9

0.41

0.29

e6/l

1.69

1602

8567

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1823

9945

1.33

26.24

6.6

6.5

24.93

24.79

mmol/l

0.73

1794

9852

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

187

553

2.42

25.89

1.1

—

(3013115) Eosinophils [#/volume] in Blood

11591

76061

1.15

25.83

6.2

6.0

0.19

0.20

e9/l

3.19

9924

65583

(3006315) Basophils [#/volume] in Blood

11284

73922

1.15

25.68

5.9

5.8

0.04

e9/l

2.95

9602

62870

(3001604) Monocytes [#/volume] in Blood

11247

73673

1.15

25.60

5.9

5.8

0.63

0.62

e9/l

1.68

9566

62676

(3042517) Benzodiazepines panel - Urine

7.13

25.49

2.3

2.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

216

687

2.25

25.41

1.1

—

(1616796) Gas panel - Central venous blood

818

3901

1.51

25.40

3.5

3.8

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

175

3.63

25.00

3.2

3.3

43.28

39.99

umol/l

0.59

136

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

200

3.42

24.81

2.2

2.9

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1973

10966

1.30

24.80

9.0

8.3

93.30

93.81

3.12

1963

10929

(3027456) Digoxin [Moles/volume] in Serum or Plasma

861

4175

1.48

24.67

3.6

3.1

0.78

0.81

nmol/l

1.28

671

3222

(3024928) Oxygen saturation in Venous blood

736

3465

1.53

24.29

3.1

3.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

226

3199

0.50

23.93

1.6

1.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1490

13809

0.75

23.20

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

18743

138630

0.86

23.15

4.6

4.8

4.33

4.49

mmol/l

71.56

16615

125547

(40767503) Oxygen content in Capillary blood by calculation

777

3759

1.49

22.54

2.8

2.6

16.10

15.99

0.29

408

2015

(3006184) Hemoglobin [Mass/volume] in Capillary blood

822

4022

1.47

22.53

2.3

127.70

127.59

g/l

0.04

639

2875

(3052592) Norovirus Ag [Presence] in Stool

123

317

2.77

22.44

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

169

514

2.35

22.10

1.1

439.96

695.03

ng/l

0.29

143

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

6.49

22.00

8.1

9.3

—

(3008037) Lactate [Moles/volume] in Venous blood

820

4034

1.46

21.87

4.0

3.4

1.65

1.62

mmol/l

0.35

803

3949

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1778

15972

0.78

21.77

1.4

1.3

—

(3000492) Spirometry study

1340

12462

0.75

21.33

1.5

—

(3021901) Oxygen saturation in Capillary blood

703

3376

1.50

21.16

2.6

2.9

—

(3012501) Base excess in Blood by calculation

793

3906

1.46

21.03

4.4

4.3

2.49

2.69

mmol/l

1.15

563

2664

(3013290) Carbon dioxide [Partial pressure] in Blood

793

3908

1.46

20.97

4.4

4.3

5.03

4.99

kpa

0.68

763

3819

(3013650) Neutrophils [#/volume] in Blood by Automated count

12844

85572

1.14

20.96

8.7

9.2

4.57

4.25

e9/l

31.34

11117

73997

(3038515) Glucose [Moles/volume] in Venous blood

780

3834

1.46

20.91

4.1

3.6

8.03

7.62

mmol/l

2.50

765

3760

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

116

3.99

20.87

1.0

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

10544

69402

1.14

20.64

6.3

6.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

187

615

2.17

20.42

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

797

3953

1.45

20.39

2.7

3.0

7.71

7.91

kpa

2.90

777

3874

(3027315) Oxygen [Partial pressure] in Blood

793

3936

1.45

20.21

4.4

4.3

8.31

8.45

kpa

1.33

762

3847

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

149

3.54

20.18

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

196

3.17

20.03

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

519

2364

1.57

19.91

2.7

2.5

4.09

4.10

mmol/l

0.10

513

2346

(3035285) Chloride [Moles/volume] in Venous blood

519

2364

1.57

19.91

2.7

2.5

105.90

105.49

mmol/l

1.01

513

2345

(3019069) Monocytes/100 leukocytes in Blood

10585

69805

1.13

19.83

6.5

6.4

8.81

8.86

0.88

9757

64672

(3022806) Fractional oxyhemoglobin in Capillary blood

489

2201

1.59

19.73

2.1

1.9

88.97

89.24

0.43

483

2172

(3006504) Eosinophils/100 leukocytes in Blood

10521

69409

1.13

19.46

6.1

2.72

2.85

6.73

9679

64248

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

202

3.07

19.10

1.1

1.2

—

(3022096) Basophils/100 leukocytes in Blood

10225

67396

1.13

19.03

6.1

0.62

0.66

11.32

9403

62306

(3018010) Neutrophils/100 leukocytes in Blood

10584

69923

1.13

18.96

6.1

6.0

59.87

58.32

30.01

9749

64869

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

4.28

18.92

1.1

1.4

46.24

42.23

0.22

(3033705) Calcium.ionized [Moles/volume] in Venous blood

509

2338

1.56

18.86

2.8

2.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

10741

71047

1.13

18.81

6.3

6.2

24.85

26.34

33.48

9900

65965

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

118

328

2.57

18.72

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

114

3.81

18.48

1.0

1.1

—

(3042936) Bacteria identified in Isolate by Culture

3715

22798

1.19

18.45

2.2

2.0

—

(40761511) CBC panel - Blood by Automated count

20884

144191

1.16

18.37

21.2

16.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

228

2959

0.54

18.32

1.2

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

149

3.40

18.27

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4904

39277

0.86

17.87

1.6

1.31

1.33

mmol/l

0.47

4079

32120

(3003694) ABO and Rh group [Type] in Blood

4580

36867

0.86

17.85

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

281

1122

1.79

17.75

1.3

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

157

2258

0.49

17.57

1.4

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

285

1148

1.78

17.49

1.3

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

264

2.67

17.07

1.6

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

149

482

2.21

17.03

2.7

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

149

482

2.21

17.03

2.8

2.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

357

4045

0.62

16.99

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1541

8724

1.27

16.68

1.5

1.7

1.60

1.58

g/l

0.51

1248

7452

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4982

31549

1.15

16.40

1.7

1.54

1.44

mg/l

0.93

3913

24504

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

4.24

16.34

1.1

1.4

16.39

13.37

0.28

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

4.83

16.16

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

265

2.61

16.00

1.8

1.19

1.17

mmol/l

0.80

256

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

663

6548

0.71

15.64

2.8

4.0

88.05

76.64

u/ml

0.20

632

6293

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

182

2.94

15.38

2.3

2.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

186

2.91

15.36

2.3

2.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

768

3985

1.38

15.32

1.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

1307

7340

1.28

15.09

1.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

157

545

2.06

15.09

1.8

2.0

56.42

57.44

ug/l

0.08

151

531

(3033658) Prothrombin time (PT) actual/Normal

6118

39485

1.13

15.01

4.4

4.1

82.65

85.80

17.31

5938

38578

(42529406) Shigella sp [Presence] in Stool by Culture

774

4039

1.37

14.92

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

771

4027

1.37

14.79

1.3

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

633

3199

1.42

14.74

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

119

375

2.26

14.55

1.5

1.2

105.72

131.52

nmol/l

1.09

270

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

19429

142232

0.88

14.44

5.2

5.5

2.46

2.60

mmol/l

85.76

17226

128234

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2828

17298

1.18

14.35

2.4

2.7

9.22

9.62

umol/l

0.35

2362

15147

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

4.25

14.01

1.1

1.4

1.13

1.57

0.24

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

103

3.53

13.97

1.0

1.2

66.00

22.21

—

(3044242) Glucose [Moles/volume] in Arterial blood

206

811

1.81

13.76

2.3

2.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2341

14167

1.19

13.39

2.6

2.5

37.27

48.55

u/l

1.01

1932

12098

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

210

839

1.79

13.38

1.7

1.4

14.23

13.88

umol/l

0.26

193

782

(3013512) EKG study

7457

48971

1.12

13.36

4.8

4.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1195

6749

1.27

13.21

4.0

4.1

25.07

24.86

mmol/l

1.39

1047

6210

(3044640) Blood type and Crossmatch panel - Blood

7565

49787

1.12

12.94

2.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

151

548

1.97

12.93

1.1

1.12

1.08

u/l

0.31

285

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

121

3.18

12.70

1.2

17.68

15.25

pmol/l

0.19

107

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

148

2.94

12.59

1.1

—

(40768800) Prostate Pathology biopsy report

405

4192

0.68

12.55

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

111

3.27

12.55

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

883

4832

1.31

12.46

5.4

4.4

—

(3022313) Gas panel - Capillary blood

1368

7907

1.24

12.41

3.6

3.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1080

0.39

12.30

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

100

316

2.26

12.23

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

469

2327

1.44

12.16

6.0

6.1

12.29

12.10

mg/l

0.38

407

2120

(3044889) 12 lead EKG panel

15263

104297

1.10

12.05

4.9

4.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.25

11.93

1.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1595

9434

1.22

11.62

9.0

8.2

24.36

mmol/l

0.01

1515

9067

(40758558) Short blood count panel - Blood

5780

37672

1.12

11.52

6.7

7.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

3.28

11.37

1.1

—

(40761536) Microorganisms panel - Urine sediment

2079

12643

1.19

11.21

5.4

4.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

159

627

1.81

10.69

1.6

1.3

—

(3019977) pH of Arterial blood

227

991

1.64

10.62

2.8

2.5

7.42

0.16

401

(40768793) Breast Pathology biopsy report

288

3071

0.66

10.49

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

328

3402

0.68

10.36

1.6

1.7

4.11

3.90

mg/l

0.12

265

2525

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2366

19263

0.86

10.18

3.0

4.1

14.46

25.45

ug/l

2.05

1945

16099

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

261

1192

1.56

10.16

1.1

—

(3000330) Specific gravity of Urine by Test strip

1448

8598

1.21

10.16

4.5

3.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

614

3291

1.34

10.10

1.5

1.6

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

5.40

10.05

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1097

9544

0.81

10.01

1.3

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

21432

149486

1.12

9.94

25.3

20.1

83.88

82.87

umol/l

2.99

21424

149422

(4034850) Laboratory test

827

4635

1.28

9.81

13.7

11.7

—

(3008898) HLA-B27 [Presence]

280

2951

0.67

9.66

1.0

1.1

—

(3037756) Immunofixation for Serum or Plasma

734

4061

1.29

9.64

1.3

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

18430

134521

0.91

9.52

20.7

16.2

72.74

74.04

ml/min/173m2

12.67

15251

111733

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.23

9.49

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

900

5118

1.26

9.49

3.6

3.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

619

3360

1.32

9.37

4.0

3.6

29.57

28.73

mg/l

0.21

430

2122

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.37

9.36

1.5

1.9

—

(4281824) Cell count and differential, peritoneal fluid

133

1648

0.57

9.31

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9029

60699

1.09

9.15

4.9

5.6

3.81

3.90

ug/l

0.08

7769

53860

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

381

1924

1.42

9.10

1.7

1.5

—

(3022145) Colonoscopy Study observation

2116

17231

0.86

9.09

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

289

1387

1.49

9.02

2.4

2.1

1.94

2.49

u/field

0.88

105

536

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1460

8779

1.19

8.97

2.4

29.38

24.50

au/ml

0.46

499

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

407

3951

0.73

8.79

2.1

3.2

212.57

879.46

u/ml

2.82

357

3587

(3051593) INR in Capillary blood by Coagulation assay

220

1003

1.57

8.71

6.5

11.9

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1216

7214

1.21

8.65

2.1

2.3

7.56

7.48

g/l

0.90

1011

6427

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1326

7936

1.20

8.59

1.3

53.07

59.26

au/ml

0.37

420

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1214

7209

1.21

8.55

2.1

2.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.94

8.39

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

635

0.36

8.34

1.4

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1209

7197

1.20

8.31

2.1

2.3

3.76

3.71

g/l

0.50

1010

6415

(3029634) Reagin Ab [Titer] in Serum by VDRL

287

1404

1.46

8.19

1.9

2.0

10.18

2.71

titre

0.66

(1002224) Polysomnography panel

390

3765

0.73

8.16

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

137

1619

0.60

8.05

1.1

1.2

—

(40757373) Influenza virus identified in Isolate

305

2.01

8.04

1.3

1.6

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

216

2303

0.66

7.99

3.3

3.5

50.48

42.33

u/ml

0.24

206

2238

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

279

1365

1.46

7.97

1.7

1.6

27.45

25.44

u/ml

0.25

288

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1024

6024

1.22

7.96

2.6

3.3

1.66

6.37

ratio

2.03

428

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

167

2.39

7.95

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

2230

17923

0.87

7.93

1.3

507.33

528.06

titre

0.23

486

4003

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

112

1384

0.57

7.85

1.1

0.65

1.51

u/ml

1.77

692

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

204

938

1.55

7.84

1.6

1.8

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1127

6703

1.21

7.83

2.2

2.4

2.96

2.98

g/l

0.28

924

5918

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1049

6197

1.21

7.82

2.6

3.4

45.74

46.61

mg/l

0.06

829

5053

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

333

1690

1.41

7.81

2.6

2.9

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

110

429

1.83

7.80

1.3

1.5

15.76

16.56

pmol/l

0.61

356

(3034860) Kappa light chains.free [Mass/volume] in Serum

1050

6209

1.21

7.76

2.6

3.4

54.73

74.74

mg/l

1.14

829

5062

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

580

0.36

7.73

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

579

0.36

7.70

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

578

0.36

7.67

1.3

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

568

3137

1.29

7.66

1.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

577

0.36

7.65

1.3

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

835

7250

0.81

7.54

1.3

238.28

246.65

u/ml

0.13

744

6625

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

551

0.35

7.52

1.5

—

(3044927) Protein electrophoresis panel - Urine

378

1980

1.36

7.37

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4529

34838

0.91

7.36

3.1

3.3

0.78

0.82

ug/l

1.27

3278

25007

(3000570) Elastase.pancreatic [Mass/mass] in Stool

823

4777

1.23

7.32

1.4

260.30

261.34

ug/g

0.05

465

2926

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

408

3847

0.75

7.32

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1131

6775

1.20

7.30

2.1

2.3

10.21

10.24

g/l

0.08

923

5934

(3003888) Timothy IgE Ab [Units/volume] in Serum

1220

0.56

7.29

1.0

1.1

4.83

3.46

u/ml

0.31

576

(3032057) Clostridioides difficile [Presence] in Stool

100

388

1.84

7.24

1.6

1.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

802

0.47

7.19

1.0

1.60

3.21

u/ml

0.88

317

(3043238) Trisomy 21 risk [Likelihood] in Fetus

495

0.33

7.17

1.3

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

21924

153610

1.11

7.14

32.6

24.9

38.37

39.73

80.39

19619

141926

(3047352) Trisomy 18 risk [Likelihood] in Fetus

481

0.32

7.09

1.3

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

862

0.49

7.02

1.0

1.20

2.53

u/ml

1.62

400

(3005033) Fetal Nuchal fold Thickness US

478

0.33

7.00

1.3

1.4

—

(3007461) Platelets [#/volume] in Blood

21926

153660

1.11

6.96

32.4

24.8

239.81

242.22

e9/l

5.66

21222

148835

(3010813) Leukocytes [#/volume] in Blood

21933

153715

1.11

6.94

32.4

24.8

7.14

6.85

e9/l

30.59

21144

148262

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

606

3420

1.27

6.93

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

331

3190

0.73

6.92

1.7

49.97

44.16

nmol/l

2.72

315

3044

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

943

5584

1.21

6.91

2.0

2.3

36.72

37.19

g/l

1.46

736

4780

(3045716) Anion gap in Serum or Plasma

169

768

1.57

6.90

2.4

10.20

9.57

mmol/l

1.17

164

753

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1180

0.57

6.85

1.0

1.1

0.81

0.88

u/ml

0.06

481

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

708

0.45

6.82

1.0

0.22

0.23

u/ml

0.02

227

(3035941) MCH [Entitic mass]

21927

153696

1.10

6.81

32.3

24.7

30.44

30.42

0.62

21439

150920

(3027923) C peptide [Moles/volume] in Serum or Plasma

169

771

1.56

6.79

1.4

1.3

1.08

1.21

nmol/l

0.75

116

596

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

320

1655

1.38

6.79

1.3

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

102

407

1.79

6.78

1.2

1.1

1840.25

1560.25

miu/ml

1.30

102

407

(3013247) Albumin in CSF/Albumin in Serum or Plasma

171

2.25

6.77

1.2

1.1

8.01

9.28

mg/g

0.62

166

(3026361) Erythrocytes [#/volume] in Blood

21927

153713

1.10

6.72

32.4

24.8

4.30

4.43

e12/l

251.02

21139

148223

(3024731) MCV [Entitic volume]

21926

153707

1.10

6.71

32.3

24.8

91.89

91.60

15.21

21440

150926

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1025

0.55

6.68

1.0

0.39

1.00

u/ml

2.43

511

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1017

6086

1.20

6.67

2.2

2.5

1.11

1.05

g/l

0.15

804

5131

(3000963) Hemoglobin [Mass/volume] in Blood

21928

153730

1.10

6.67

32.7

25.0

129.69

133.82

g/l

282.61

21436

150970

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

172

792

1.55

6.65

2.1

1.9

15.82

16.16

nmol/l

0.20

157

732

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

750

4358

1.23

6.64

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1087

0.56

6.63

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

705

0.46

6.52

1.5

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

117

492

1.70

6.51

1.1

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1282

7846

1.17

6.48

2.7

3.3

4.30

4.37

pmol/l

1.70

1080

6865

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.10

6.47

1.2

1.1

—

mmol/l

—

(3017509) Phencyclidine [Presence] in Urine

3.25

6.47

3.4

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

194

923

1.50

6.47

2.0

2.1

16.52

26.99

umol/l

1.04

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1088

6571

1.19

6.45

2.8

0.36

0.35

u/ml

0.54

630

3789

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

757

6527

0.82

6.43

2.5

3.3

222.91

1964.67

u/ml

3.34

625

5598

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

416

2266

1.31

6.30

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

268

2627

0.72

6.30

1.5

251.33

200.46

pmol/l

0.32

257

2558

(3002523) Influenza virus A Ag [Presence] in Specimen

1086

0.58

6.24

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

684

3964

1.23

6.24

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

180

850

1.51

6.23

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

180

850

1.51

6.23

1.3

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

785

4621

1.22

6.16

2.6

3.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3199

20837

1.11

6.10

3.0

4.2

245.12

247.92

u/l

0.47

2915

19667

(3003338) MCHC [Mass/volume]

16120

111778

1.07

6.07

30.3

22.4

330.80

331.62

g/l

23.30

15880

110860

(3000012) Reticulocyte production index

489

2737

1.28

6.04

2.0

2.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

103

428

1.72

6.02

1.6

1.4

1535535.71

1649780.56

iu/ml

0.05

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

593

0.44

5.96

1.3

1.4

1.61

1.54

g/l

0.64

593

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

502

0.40

5.95

1.4

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

385

0.31

5.94

1.4

1.5

—

(3037121) Protein [Mass/volume] in Urine

965

5817

1.19

5.88

2.7

3.0

0.37

0.32

g/l

0.70

388

2486

(3023511) Choriogonadotropin [Units/volume] in Urine

120

524

1.63

5.84

1.6

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4111

27154

1.09

5.83

1.3

1.2

1.67

1.80

u/ml

0.27

976

6583

(3045142) Bone marrow Pathology biopsy report

203

2053

0.70

5.79

1.2

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

844

0.54

5.79

1.2

1.4

127.06

173.13

pmol/l

2.14

844

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

125

1378

0.64

5.59

1.7

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

834

4992

1.20

5.53

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

867

5210

1.19

5.50

1.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

7.12

5.49

2.2

1.8

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

230

1174

1.40

5.38

1.3

417.78

373.20

titre

0.08

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.66

5.34

1.6

1.5

558.61

433.21

nmol/l

0.36

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

517

2961

1.25

5.32

1.1

20.29

10.79

u/ml

0.26

221

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

313

1685

1.33

5.24

1.4

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

313

1685

1.33

5.24

1.4

1.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

223

1138

1.40

5.24

1.3

52.27

64.30

titre

0.36

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1312

10618

0.87

5.21

2.2

2.1

11.66

11.92

nmol/l

0.46

1103

9192

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

206

1038

1.42

5.20

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

201

1993

0.72

5.16

3.8

3.3

7.79

10.28

nmol/l

0.33

196

1935

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

397

0.38

5.11

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.66

5.05

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

217

0.26

5.03

1.1

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

313

1.75

4.94

1.0

1.1

—

(40768443) Skin Pathology biopsy report

883

7311

0.85

4.82

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

2.63

4.80

1.7

1.5

25.14

23.09

mmol/l

1.26

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

285

1.77

4.76

1.2

—

(4200892) Spirometry reversibility

1455

11624

0.88

4.75

1.5

1.4

—

(3017569) Oxygen content in Arterial blood

172

857

1.43

4.67

2.3

2.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

134

637

1.50

4.62

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

640

3808

1.20

4.60

1.4

1.6

—

(3051651) Icteric interference index of Serum or Plasma

192

979

1.40

4.59

3.6

4.0

—

(3051611) Lipemic interference index of Serum or Plasma

328

1813

1.29

4.59

3.6

3.4

—

(3045414) Leukocytes [Presence] in Urine

1084

6737

1.15

4.57

2.1

1.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5678

38320

1.07

4.53

2.5

—

(3012516) Albumin [Mass/volume] in Urine

6882

51249

0.94

4.52

3.1

3.3

606.72

384.78

mg/l

2.68

4538

32659

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

500

2925

1.22

4.31

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7101

48341

1.06

4.30

4.5

4.7

21.69

22.31

2.86

3542

25790

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

113

1191

0.67

4.18

1.2

2.83

3.01

u/ml

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

856

5274

1.16

4.11

2.1

2.4

0.04

g/l

0.14

740

4795

(3007463) Buprenorphine [Presence] in Urine

5.02

4.08

2.8

10.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

442

2569

1.23

4.08

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2317

15163

1.10

4.03

1.7

1.6

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

158

1557

0.72

4.01

2.5

3.8

45.10

54.53

u/ml

0.28

151

1528

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

250

0.31

4.00

1.1

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

248

1.75

3.99

1.0

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

284

1575

1.29

3.94

1.3

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

100

464

1.54

3.93

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

123

1259

0.69

3.91

1.1

1.2

49.90

38.27

u/ml

—

104

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

255

1399

1.30

3.85

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

123

1254

0.70

3.84

1.1

1.2

85.11

78.52

u/ml

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

818

0.63

3.84

10.2

3.7

13.62

13.26

2.80

808

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

116

1194

0.69

3.82

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

235

1277

1.31

3.81

1.2

1.3

1.31

1.46

nmol/l

1.40

216

1149

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

135

673

1.43

3.75

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

272

2457

0.79

3.73

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

356

2045

1.24

3.71

1.5

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

800

4946

1.16

3.70

2.2

2.4

0.00

g/l

0.15

688

4482

(3049717) Cytology report of Urine Cyto stain

1215

7723

1.13

3.70

2.5

2.8

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

255

2318

0.78

3.69

1.8

177.96

195.16

pmol/l

2.53

222

2146

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

505

0.53

3.69

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

4.27

3.60

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

21274

149667

1.07

3.58

11.9

11.5

23.76

25.37

u/l

10.19

20219

143263

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1472

9479

1.11

3.57

2.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

777

0.63

3.57

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

200

1865

0.76

3.55

1.3

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

402

1.54

3.52

1.3

1.6

0.44

0.37

ug/l

0.71

245

(3012920) Ethanol [Mass/volume] in Serum or Plasma

5.82

3.52

1.8

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

162

850

1.36

3.38

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

235

1301

1.29

3.37

2.5

2.0

2263.05

3123.59

u/l

0.28

477

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.67

3.35

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

343

2979

0.82

3.34

1.2

0.58

13.85

u/ml

—

(36660697) Celiac disease serology panel - Serum

1525

9898

1.10

3.21

1.2

—

(3025130) Human papilloma virus identified in Specimen

100

1020

0.70

3.20

1.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

180

1.78

3.18

1.4

1.7

40.02

47.34

umol/l

1.17

180

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

114

2.00

3.18

1.4

1.7

2.00

0.76

mmol/l

0.64

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

212

1.71

3.17

3.1

2.8

0.59

0.53

u/field

0.18

212

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

779

4869

1.14

3.15

2.2

2.4

0.00

g/l

-0.00

685

4468

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

405

3436

0.84

3.11

1.2

1.3

6.26

5.24

u/ml

0.15

567

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

873

0.68

3.01

1.6

1.3

1.23

1.48

u/ml

0.16

510

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

170

1579

0.76

3.00

1.2

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

169

911

1.32

3.00

2.2

1.9

2.23

2.80

u/field

0.56

110

621

(40768441) Liver Pathology biopsy report

105

1047

0.71

2.98

1.3

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

130

675

1.37

2.95

1.2

4.0

62.82

741.58

mg/l

0.84

476

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

3.42

2.94

1.1

1.5

11.50

47.84

e6/l

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

398

2375

1.20

2.93

1.9

2.2

32.66

32.59

0.11

388

2366

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

154

1.80

2.90

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

404

3402

0.84

2.88

1.2

8.85

6.23

u/ml

0.21

379

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

149

1398

0.76

2.85

1.7

1.8

4.87

4.32

mg/l

0.51

136

1323

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

291

2521

0.82

2.83

1.7

1.8

23.11

24.00

ug/l

0.07

277

2457

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.28

2.83

1.3

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

262

1506

1.24

2.82

2.6

3.1

19.29

45.49

mg/l

3.45

192

1089

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

151

809

1.33

2.82

1.0

1.1

2.87

8.18

nmol/l

1.39

172

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

907

7203

0.89

2.81

1.1

1.2

101.47

131.04

iu/ml

1.44

290

2424

(21494434) Karyotype in Bone marrow

181

1651

0.78

2.80

1.1

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

104

1023

0.72

2.75

1.0

1.1

—

(3044941) Cell count panel - Synovial fluid

423

2555

1.18

2.74

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2700

20406

0.93

2.73

4.6

5.0

33.94

33.05

3.43

1727

13464

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

441

3668

0.85

2.72

1.2

32.78

40.94

u/ml

0.28

199

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

155

1436

0.77

2.72

1.2

7.91

7.87

mmol/l

0.05

133

1190

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

429

2598

1.18

2.70

1.4

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

429

2598

1.18

2.70

1.4

1.6

—

(3001186) Copper [Moles/volume] in Serum or Plasma

245

1.60

2.69

1.3

1.1

16.38

16.67

umol/l

0.18

218

(3020682) Albumin/Creatinine [Ratio] in Urine

7346

53976

0.96

2.67

3.6

3.9

11.73

9.27

mg/mmol

2.79

4694

33764

(3024980) IgG subclass 4 [Mass/volume] in Serum

254

2215

0.81

2.66

1.6

1.5

0.70

0.86

g/l

1.51

192

1636

(3002619) Bacteria identified in Specimen by Culture

314

1.52

2.64

1.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

243

2126

0.81

2.63

2.3

2.5

45.21

1246.14

u/ml

1.90

238

2092

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

356

2127

1.19

2.63

1.3

1.4

—

(3017732) Neutrophils [#/volume] in Blood

1496

9802

1.09

2.63

3.8

3.1

5.96

5.46

e9/l

0.48

1046

7343

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

326

1.51

2.62

1.4

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

684

4300

1.14

2.60

2.1

2.3

163.34

109.61

ug/min

1.48

352

2488

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

141

0.35

2.59

1.3

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

339

2020

1.20

2.59

2.2

2.5

1.15

1.21

g/24h

0.16

134

977

(3026493) Urate [Moles/volume] in Serum or Plasma

5650

41726

0.95

2.54

2.7

2.9

6667.44

5746.77

umol/l

0.67

4596

35634

(3014148) Varicella zoster virus Ab [Titer] in Serum

193

1087

1.27

2.52

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

331

1977

1.19

2.48

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

343

2059

1.19

2.43

1.3

1.4

—

(3036489) Thrombin time

824

5266

1.12

2.42

1.8

1.9

21.58

21.93

0.58

746

4713

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

222

0.45

2.41

4.7

3.3

125.29

138.64

ng/l

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

289

0.52

2.41

1.4

1.6

1.54

2.52

ug/l

2.26

158

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

343

2061

1.19

2.41

1.3

1.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

107

559

1.36

2.41

1.7

1.6

4.73

5.27

nmol/l

0.10

483

(3017704) Immunofixation for Urine

184

1038

1.26

2.39

1.2

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

343

2064

1.18

2.38

1.3

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

259

0.49

2.37

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

282

1.52

2.37

1.2

1.1

3.56

10.56

pmol/l

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

413

2525

1.17

2.36

1.3

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

172

964

1.27

2.36

1.7

1.9

—

(40768797) Stomach Pathology biopsy report

2874

21569

0.94

2.36

1.3

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

396

0.59

2.36

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

396

0.59

2.36

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

396

0.59

2.36

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

396

0.59

2.36

1.2

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

323

0.55

2.34

1.1

1.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

116

617

1.34

2.34

5.9

6.6

25.02

24.88

mmol/l

0.13

102

551

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

477

3890

0.87

2.32

1.7

1.8

13.03

11.73

mg/l

0.67

434

3563

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

687

0.69

2.32

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

214

1867

0.81

2.31

1.4

1.3

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

2.30

0.0

1.0

—

8.40

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

693

5512

0.89

2.28

2.0

1.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

283

0.53

2.27

2.4

1.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

151

1.70

2.25

15.0

9.5

—

(3004616) Nuclear Ab [Presence] in Serum

213

1854

0.82

2.25

1.2

1.3

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

4.15

2.25

1.0

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

19040

133998

1.04

2.22

6.9

6.6

41.76

40.66

mmol/mol

36.63

17026

121596

(40761995) Spermatozoa Progressive [#/volume] in Semen

111

0.32

2.18

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

111

0.32

2.18

6.0

5.9

—

(3010375) cycloSPORINE [Mass/volume] in Blood

610

0.69

2.16

31.4

27.1

102.73

108.39

ug/l

0.42

519

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

287

0.55

2.16

1.1

—

(3028433) Virus identified in Specimen by Culture

517

1.35

2.12

1.1

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

167

1480

0.80

2.12

1.3

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

343

2089

1.17

2.10

1.3

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

16989

119346

1.04

2.09

26.2

19.9

15.45

15.44

0.06

16671

117063

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

804

5180

1.11

2.08

1.1

1.69

9.22

u/ml

0.76

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

311

1881

1.18

2.08

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

255

2161

0.84

2.07

1.5

1.4

32.42

30.96

iu/l

0.25

208

1833

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

445

2769

1.15

2.06

3.3

3.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

778

6110

0.90

2.06

1.5

1.8

38.46

38.54

u/l

0.03

647

5224

(3014599) Egg white IgE Ab [Units/volume] in Serum

372

0.61

2.05

1.0

0.35

0.66

u/ml

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

352

2902

0.86

2.04

1.2

1.77

5.22

u/ml

2.01

228

(3020874) Milk IgE Ab [Units/volume] in Serum

397

0.63

2.03

1.0

0.69

0.72

u/ml

0.02

140

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

384

2369

1.16

2.01

1.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.56

1.98

1.0

1.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

455

2844

1.14

1.98

3.3

4.57

4.30

e9/l

1.39

455

2835

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

3.16

1.97

1.4

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

522

4180

0.89

1.97

1.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

124

0.40

1.95

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.44

1.95

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

620

0.71

1.92

1.1

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

550

0.70

1.87

1.1

2.94

4.54

u/ml

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

845

0.76

1.86

5.3

6.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

194

1.54

1.86

1.5

2.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

373

2313

1.15

1.85

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

338

2081

1.16

1.85

1.3

1.4

—

(3015183) Erythrocyte sedimentation rate

395

0.65

1.83

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

180

1553

0.82

1.82

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

224

1.49

1.81

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

10210

71230

1.03

1.76

2.8

2.7

—

(3030313) Adrenal Ab [Titer] in Serum

2.03

1.76

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

655

5140

0.90

1.76

1.2

1.43

0.79

u/ml

0.51

480

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

288

2378

0.86

1.75

2.0

1.9

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

295

0.60

1.75

1.0

0.09

1.12

u/ml

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

631

4958

0.90

1.74

1.9

1.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

217

1831

0.84

1.73

1.1

1.58

1.55

g/l

0.43

191

1625

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

176

1513

0.83

1.73

1.1

—

(3024263) Appearance of Synovial fluid

147

845

1.24

1.73

1.2

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

467

2958

1.13

1.70

1.5

1.6

—

(3022689) Creatine [Moles/volume] in Urine

462

0.69

1.66

1.3

1.4

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.37

1.66

1.4

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

146

1272

0.82

1.66

1.1

4.28

4.00

u/ml

0.07

401

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

519

0.71

1.64

1.7

1.9

19.15

368.63

ug/l

1.21

487

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

140

1222

0.81

1.62

1.1

94.52

94.13

0.06

127

1125

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

242

2010

0.86

1.62

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

372

2332

1.14

1.62

2.1

28.84

26.27

mg/l

0.32

101

602

(3020393) Adenovirus Ag [Presence] in Stool

144

1.58

1.61

1.1

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

391

0.67

1.60

2.3

1.8

2.85

5.87

ug/l

1.08

279

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

111

624

1.27

1.60

2.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

376

3025

0.88

1.60

1.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

261

0.60

1.60

2.8

3.0

7.07

7.30

mg/l

0.09

212

(3006442) Creatine [Moles/volume] in Serum or Plasma

155

905

1.22

1.60

2.0

1.6

90.90

93.23

umol/l

0.19

155

905

(40765096) Chromosome analysis panel by Banding

524

0.72

1.59

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

363

2275

1.14

1.59

2.1

1.7

399.44

292.25

mu/l

3.73

327

2090

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

293

2395

0.87

1.59

1.1

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

206

0.55

1.58

1.6

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

389

1.34

1.56

1.2

—

(3007147) Virus identified in Stool by Electron microscopy

3.56

1.53

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.39

1.53

1.0

1.3

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.24

1.52

1.1

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

137

795

1.23

1.51

1.1

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

186

1568

0.84

1.51

1.1

113.76

116.46

0.55

164

1382

(3020491) Glucose [Moles/volume] in Blood

182

1088

1.19

1.49

2.0

7.54

7.19

mmol/l

0.73

138

735

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

156

0.50

1.49

1.0

—

(3006245) CD3-CD19+ cells/100 cells in Blood

430

1.31

1.48

2.0

1.9

9.07

11.95

1.02

383

(3000285) Sodium [Moles/volume] in Blood

235

1.42

1.48

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

523

4107

0.90

1.48

1.9

1.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

638

0.76

1.47

1.8

1.9

2979.25

3168.72

e6/l

0.02

440

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

443

1.30

1.47

1.1

1.2

—

(3035880) pH of Pleural fluid

193

1162

1.18

1.47

1.2

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

350

2203

1.13

1.46

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

131

1136

0.82

1.46

4.2

5.1

102.03

116.88

u/ml

0.08

334

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

196

1637

0.85

1.44

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

154

0.51

1.44

4.0

2.3

194.73

390.96

umol/l

0.95

145

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

278

0.64

1.42

1.3

1.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

368

2936

0.89

1.41

4.8

4.7

465.51

1518.84

iu/ml

1.06

448

(3035933) Granulocytes/100 leukocytes in Blood

224

0.60

1.38

5.0

1.4

—

(3045424) Erythrocytes [Presence] in Urine

404

2576

1.12

1.38

1.6

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

623

4062

1.09

1.37

1.6

18255.38

14650.71

e6/l

0.74

447

2933

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

154

915

1.20

1.37

1.1

1.0

293.36

291.48

mg/l

0.11

135

809

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

215

1.42

1.37

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

176

1059

1.18

1.37

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

301

0.66

1.36

1.1

1.2

—

1080.00

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

137

806

1.21

1.36

1.1

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

128

748

1.22

1.36

2.2

1.7

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

493

1.27

1.35

4.1

6.0

59.63

72.48

3.44

399

(3035637) Corticotropin [Mass/volume] in Plasma

277

1728

1.14

1.35

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

404

2580

1.12

1.35

1.6

1.8

4.38

4.73

mmol/24h

1.22

330

2199

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.03

1.35

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

228

1.41

1.34

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

611

3986

1.09

1.34

1.6

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

628

0.77

1.34

1.3

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

234

1444

1.15

1.34

1.4

13.52

13.18

u/l

0.29

221

1392

(40758292) HTLV I+II Ab panel - Serum

195

0.58

1.33

1.1

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

19714

139243

1.03

1.32

5.3

5.2

6.19

6.07

mmol/l

21.77

17369

124131

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.48

1.32

3.8

4.5

—

(3014051) Protein [Presence] in Urine by Test strip

633

4141

1.09

1.31

2.9

2.7

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.88

1.29

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

140

831

1.20

1.28

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.99

1.28

1.1

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

131

773

1.21

1.28

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

131

775

1.20

1.25

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

724

0.80

1.24

1.3

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

724

0.80

1.24

1.3

1.9

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

136

1153

0.84

1.24

2.2

2.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

162

1352

0.85

1.23

1.7

1.4

47.40

24.86

iu/ml

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.73

1.23

1.2

1.0

192.11

161.89

pmol/l

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.89

1.22

1.0

0.01

0.26

u/ml

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

401

2579

1.11

1.21

1.3

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

203

1.40

1.21

1.2

81.59

114.79

ug/l

1.07

127

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

562

0.77

1.21

1.8

5066.75

12849.56

e6/l

0.88

308

(3010144) Erythrocytes [#/volume] in Synovial fluid

256

1605

1.14

1.20

1.3

1.4

146608.02

147473.61

e6/l

0.01

162

1111

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

186

1140

1.16

1.19

1.4

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

458

1.26

1.19

1.1

1.2

—

(3003577) Lead [Moles/volume] in Blood

1.70

1.18

1.3

1.1

0.11

umol/l

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.73

1.16

3.0

4.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

162

986

1.17

1.15

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

675

0.80

1.13

1.3

1.4

—

(3000494) Fungus identified in Specimen by Culture

2550

17503

1.04

1.12

1.5

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1680

12498

0.95

1.11

2.9

60.38

59.95

ml/min/173m2

0.18

742

5318

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

235

1891

0.88

1.10

1.8

1.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

344

0.72

1.10

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

107

1.53

1.08

1.4

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.48

1.07

1.2

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

274

2178

0.89

1.06

1.3

0.31

0.26

nmol/l

0.22

173

(3005719) IgG [Mass/volume] in Serum or Plasma

1575

10713

1.05

1.06

2.8

10.69

10.63

g/l

0.16

1404

9759

(3004451) EKG impression Narrative

156

955

1.16

1.05

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

283

1.31

1.05

2.1

1.8

1388.52

1212.12

e6/l

0.04

151

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

323

2074

1.11

1.05

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.46

1.03

1.0

1.3

385.40

336.77

umol/24h

—

(3023383) Lactate [Moles/volume] in Pleural fluid

110

655

1.20

1.03

1.2

1.3

3.55

3.37

mmol/l

0.26

604

(3042631) Mycobacterium sp identified in Specimen

349

2734

0.91

1.03

2.4

2.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

315

0.72

1.03

1.1

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

969

6511

1.06

1.03

2.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

615

4701

0.93

1.02

1.5

1.4

18.47

14.23

iu/ml

0.22

112

(44786800) Granulocytes/100 leukocytes in Body fluid

278

1.31

1.02

1.3

16.83

23.88

1.02

217

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.51

1.00

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

175

1086

1.15

1.00

3.0

2.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1790

12235

1.04

0.99

1.6

1.5

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

178

0.64

0.98

1.0

1.1

6.90

20.52

iu/ml

—

(44813793) Dust mix specific IgE antibody measurement

808

0.84

0.96

1.0

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

275

2170

0.90

0.96

1.3

0.65

2.35

nmol/l

1.36

258

2066

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

730

0.83

0.95

1.3

1.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

492

3240

1.08

0.95

1.4

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

1744

12907

0.96

0.95

3.8

4.0

0.11

0.00

559

4370

(3020618) Glucose [Moles/volume] in Synovial fluid

1.64

0.94

1.1

1.0

5.01

5.48

mmol/l

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.25

0.94

1.2

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

160

993

1.15

0.93

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

118

717

1.17

0.91

1.4

1.6

14.79

10.26

umol/l

0.41

505

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

140

0.61

0.91

1.0

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

632

0.82

0.90

1.4

1.5

9.52

9.73

ug/l

0.04

574

(3013166) Neutrophils/100 leukocytes in Synovial fluid

515

1.20

0.90

1.2

1.4

71.17

57.12

3.34

444

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

678

0.83

0.90

1.2

—

(40762814) Titanium [Mass/volume] in Blood

387

0.77

0.89

2.0

2.2

3.26

3.46

ug/l

0.18

136

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

221

1756

0.89

1.2

4.02

4.37

u/ml

0.08

606

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

588

3911

1.07

0.89

2.7

2.8

1.75

1.73

mg/l

0.23

512

3511

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

318

2479

0.91

0.89

1.2

31.62

45.63

u/ml

1.37

250

(3042111) Morphology [Interpretation] in Bone marrow Narrative

402

3101

0.92

0.88

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.82

0.88

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

121

0.59

0.87

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

155

1.38

0.87

1.2

1.7

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.03

0.87

1.2

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

289

1870

1.10

0.86

1.3

1.4

6.44

6.34

mmol/l

0.24

262

1738

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

421

1.22

0.85

1.4

1.3

29.11

34.02

0.49

277

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

500

3817

0.93

0.85

2.2

2.3

204.93

204.82

0.01

468

3605

(40761539) Cells [Type] in Urine sediment by Light microscopy

460

1.21

0.85

1.2

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

101

0.56

0.84

1.5

198.88

193.32

ng/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

517

0.81

0.84

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

679

4550

1.06

0.84

1.3

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

1.47

0.82

1.2

1.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

127

1.40

0.81

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

176

1406

0.89

0.80

1.3

1.4

2.84

2.94

g/l

0.25

123

957

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

379

1.22

0.80

2.3

2.5

7.43

7.67

mmol/l

0.23

238

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

233

1498

1.11

0.80

1.3

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

233

1498

1.11

0.80

1.3

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

233

1498

1.11

0.80

1.3

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

176

1405

0.89

0.80

1.3

1.4

7.10

6.99

g/l

0.12

121

956

(3024139) IgG subclass 3 [Mass/volume] in Serum

176

1404

0.89

0.79

1.3

1.4

0.40

0.44

g/l

0.71

125

956

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

106

648

1.16

0.79

1.8

2.0

95.00

95.85

0.09

611

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

129

1048

0.88

0.78

2.2

2.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

116

948

0.87

0.76

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

440

0.81

0.76

2.2

2.7

—

(3001729) Color of Synovial fluid

135

1.37

0.76

1.2

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

447

1.19

0.76

1.7

1.9

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

116

947

0.87

0.76

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

316

2441

0.92

0.76

1.4

16.19

19.54

u/ml

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.60

0.76

1.5

1.6

0.99

1.48

mg/l

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.60

0.76

1.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

116

946

0.87

0.75

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

540

0.83

0.74

1.5

1.8

120441.08

28771.79

u/ml

0.41

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.56

0.74

1.2

1.6

—

(3025159) Blasts/100 leukocytes in Blood

1640

12074

0.96

0.73

3.9

4.0

0.31

0.40

0.18

459

3602

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.54

0.73

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

192

1.30

0.73

1.7

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

198

0.72

1.2

1.1

—

(3014891) Appearance of Pleural fluid

294

1.23

0.72

1.1

1.3

—

(4062490) Immunoglobulin typing, IgG

177

1401

0.90

0.72

1.3

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

116

942

0.88

0.71

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

116

942

0.88

0.71

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

126

1017

0.88

0.71

1.1

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

7229

52151

0.98

0.71

3.2

7.00

7.19

mmol/l

3.16

5875

42871

(3017315) Amylase [Enzymatic activity/volume] in Urine

129

809

1.14

0.70

1.1

1.2

240.77

350.69

u/l

0.76

115

745

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

505

0.83

0.70

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

116

940

0.88

0.70

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

314

2415

0.92

0.70

1.4

10.70

10.87

u/l

0.08

242

1942

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

122

763

1.14

0.69

1.2

1.4

61.30

65.25

0.58

626

(3002179) Metamyelocytes/100 leukocytes in Blood

1679

12338

0.97

0.69

3.5

3.8

0.73

0.69

0.16

564

4324

(3048929) Epstein Barr virus Ab [Presence] in Serum

375

2863

0.93

0.69

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.87

0.68

2.4

2.8

2.00

1.87

mu/l

—

(40758358) Immune stain study

0.52

0.68

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

342

1.21

0.68

5.2

6.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

646

4843

0.95

0.67

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

547

4120

0.94

0.67

2.1

88.41

88.50

0.03

523

3941

(43055514) Macroprolactin [Presence] in Serum or Plasma

145

1.33

0.66

1.2

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

670

0.86

0.66

1.0

1.1

13.46

10.83

iu/ml

0.27

144

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

215

1.26

0.65

1.0

1.6

—

39.99

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

540

4062

0.94

0.64

1.6

1.5

18.07

4.67

iu/ml

0.69

150

965

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

283

2176

0.92

0.64

1.4

111.07

119.72

u/ml

0.80

494

(3035611) Eosinophils/100 leukocytes in Synovial fluid

115

1.36

0.64

1.1

1.7

1.16

0.77

0.29

(3035947) Staphylolysin Ab [Units/volume] in Serum

126

796

1.13

0.63

1.2

1.1

3.57

4.40

iu/ml

—

(3013762) Body weight Measured

1.67

0.63

1.0

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

374

2843

0.94

0.63

1.3

38.88

43.29

u/l

0.26

320

2440

(3042010) Triglyceride [Moles/volume] in Pleural fluid

287

1.22

0.62

1.1

1.3

0.63

1.35

mmol/l

1.36

188

(3007566) Smooth muscle Ab [Titer] in Serum

531

3575

1.06

0.62

1.2

113.57

148.96

titre

0.62

280

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

224

0.76

0.62

1.1

1.2

5.78

150291.59

nmol/l

0.72

177

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.62

0.0

1.6

—

16.93

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

391

2965

0.94

0.61

3.1

3.5

1.71

1.52

0.40

331

2603

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

183

0.74

0.61

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

230

1.24

0.60

1.1

1.2

2133.33

141.16

ng/l

0.52

154

(3034426) Prothrombin time (PT)

396

0.83

0.60

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

494

3324

1.06

0.60

1.3

1.2

68.89

161.08

titre

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

129

1.32

0.60

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

0.04

—

(3017181) Myelocytes/100 leukocytes in Blood

1862

13609

0.97

0.58

3.8

4.0

0.98

0.97

0.05

673

5035

(3003129) Base excess in Capillary blood by calculation

481

1.15

0.57

1.6

1.8

1.61

0.40

mmol/l

2.09

454

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

501

1.15

0.57

1.2

1.4

20.35

21.04

0.08

426

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.38

0.57

1.0

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

126

803

1.12

0.57

2.9

2.6

40.15

37.23

0.86

462

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.58

0.54

1.5

4.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

119

1.32

0.54

1.0

1.1

10.50

10.73

u/l

0.03

119

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

427

2874

1.06

0.53

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.39

0.53

1.0

1.1

0.02

1.49

u/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

324

2456

0.94

0.53

1.4

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.46

0.53

48.7

12.5

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

466

0.85

0.53

2.3

2.1

16.07

44.93

u/l

3.23

429

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

105

0.68

0.53

1.1

1.3

—

29818.00

—

(3041806) Other cells [#/volume] in Blood by Manual count

105

0.68

0.53

1.7

1.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.67

0.53

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

234

1545

1.08

0.52

1.2

1.3

18.21

12.27

u/l

1.46

210

1434

(3009871) Measles virus Ab [Titer] in Serum

288

0.82

0.52

1.6

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

579

0.87

0.52

2.2

1.9

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.36

0.51

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

245

1870

0.93

0.50

1.2

167.31

220.17

miu/ml

1.06

662

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

645

0.88

0.50

7.9

4.6

4534.39

545.64

u/ml

0.63

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

245

1869

0.93

0.50

1.2

1.3

289.57

294.75

pmol/l

0.08

202

1579

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

117

922

0.90

0.50

1.3

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

795

5873

0.96

0.49

1.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

140

1.27

0.49

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

378

2545

1.06

0.49

1.3

1.5

3919.30

2212.47

e6/l

1.07

282

1852

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

630

1.12

0.48

2.5

2.6

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

167

1.24

0.46

1.6

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.32

0.46

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

331

1.16

0.46

2.9

2.8

14.85

14.71

ml/dl

0.13

308

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.42

0.46

1.0

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

345

1.16

0.45

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

248

1882

0.94

0.45

1.3

—

nmol/l

—

(3026480) Teichoate Ab [Titer] in Serum

155

1.24

0.45

1.0

1.1

—

2.00

—

(3044007) Cell count panel - Peritoneal fluid

501

0.88

0.42

1.8

1.9

—

(3012898) Urea [Moles/volume] in Urine

137

1.25

0.42

1.1

1.3

132.39

153.47

mmol/l

0.47

115

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.42

0.0

1.5

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.42

0.0

1.0

—

12.65

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

131

855

1.09

0.42

1.4

1.3

27.93

30.16

u/l

0.34

103

697

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.55

0.42

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

355

1.14

0.41

1.1

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

216

1.19

0.40

2.4

2.6

63.99

84.08

mg/l

—

(40765089) Chromosome analysis panel - Blood by G-banded

139

0.77

0.40

1.1

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1091

7978

0.97

0.40

1.4

1.3

—

(3022475) Manganese [Moles/volume] in Blood

0.68

0.40

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

293

1974

1.06

0.40

3.6

3.9

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.38

0.40

1.2

1.1

186.25

300.39

nmol/l

2.86

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.66

0.40

1.0

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

105

819

0.91

0.40

1.4

1.5

3.97

4.03

0.02

184

(3002331) Protein [Mass/volume] in Peritoneal fluid

400

0.87

0.40

1.3

24.60

45.46

g/l

0.80

318

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

154

0.79

0.39

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

246

1855

0.94

0.39

2.6

3.5

59.04

57.69

0.41

191

1542

(3006567) Chloride [Moles/time] in 24 hour Urine

1.42

0.39

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

412

2805

1.05

0.38

2.2

2.4

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

169

0.80

0.38

11.2

8.0

0.35

0.47

umol/l

0.34

152

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

224

1692

0.94

0.38

1.0

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

188

1428

0.94

0.38

1.1

0.97

2.09

iu/ml

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

119

920

0.92

0.38

1.3

1.8

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.69

0.38

2.0

2.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

106

823

0.92

0.37

1.6

1.4

0.25

0.23

nmol/l

0.19

599

(3047189) Immunofixation for 24 hour Urine

116

897

0.92

0.37

1.6

1.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

289

1953

1.05

0.37

1.2

1.3

501.42

429.85

u/l

0.27

273

1856

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

1.37

0.36

1.5

1.6

2.71

2.17

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.37

0.36

1.5

1.6

1.89

1.92

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.37

0.36

1.5

1.6

3.53

3.28

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.37

0.36

1.5

1.6

6.36

2.34

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.37

0.36

1.5

1.6

4.78

1.26

mg/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1845

13379

0.98

0.36

1.6

1.5

—

(3021788) Differential panel - Synovial fluid

450

3076

1.04

0.36

1.5

—

(3034770) Mitochondria Ab [Titer] in Serum

520

3566

1.04

0.35

1.2

361.00

932.98

titre

—

104

(3036525) Urea [Moles/time] in 24 hour Urine

102

1.26

0.35

3.4

2.9

—

(3021589) Normoblasts [#/volume] in Blood

9179

64868

1.01

0.35

12.0

10.4

0.00

e9/l

1.90

7464

52925

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

419

2864

1.04

0.34

1.7

1.5

0.84

0.83

nmol/l

0.10

340

2354

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

150

996

1.07

0.34

1.2

31.76

26.80

u/l

0.41

127

842

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.33

0.34

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

227

1705

0.95

0.34

1.2

3.12

3.92

u/ml

0.77

101

770

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

109

1.24

0.33

1.1

1.15

1.06

u/field

0.35

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

265

0.86

0.33

11.0

11.5

5.93

5.26

mmol/l

0.43

265

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.27

0.33

1.1

36.91

122.04

u/l

0.60

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

301

2242

0.95

0.33

2.2

2.4

629.85

5366.16

u/ml

0.70

149

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

103

1.24

0.32

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

423

2897

1.04

0.32

1.4

1.5

31.56

32.09

g/l

0.37

380

2595

(3028026) IgM [Mass/volume] in Serum or Plasma

1162

8453

0.98

0.32

1.9

2.0

1.61

1.37

g/l

1.31

1010

7593

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.38

0.32

1.1

1.3

—

(3033799) Differential panel - Peritoneal fluid

556

0.91

0.32

2.0

1.8

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.31

0.31

1.1

1.17

0.90

u/field

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

384

0.89

0.31

2.5

2.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

520

1.09

0.31

1.2

1.25

0.39

g/l

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.70

0.31

1.1

1.4

—

(3020650) Glucose [Presence] in Urine

303

1.13

0.31

2.3

1.4

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

256

1.14

0.31

1.2

1.4

73.14

72.92

0.01

215

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

203

1524

0.95

0.31

1.3

1.2

—

36.63

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.31

0.31

8.1

8.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

215

1609

0.95

0.29

1.2

45.19

55.79

u/ml

0.30

107

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

197

1.16

0.29

1.0

—

(3045788) Cell count panel - Pleural fluid

284

1936

1.04

0.29

1.4

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

500

0.91

0.28

2.3

1.8

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

139

0.82

0.28

1.1

1.6

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

326

1.11

0.28

1.3

1.2

1.21

49.79

mg/l

1.24

247

(3032868) Hemoglobin electrophoresis panel in Blood

0.77

0.27

1.7

1.5

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

123

0.81

0.27

1.5

1.3

1.00

0.86

ml/s/173m2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

298

2037

1.04

0.27

1.8

2.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

266

1.12

0.27

1.1

1.3

37.07

300.32

u/l

0.90

194

(3008536) Aspergillus sp Ab [Presence] in Serum

327

0.89

0.27

1.5

1.8

—

(3027035) Albumin [Mass/time] in 24 hour Urine

161

0.84

0.27

1.3

—

685.98

—

(3013293) Extractable nuclear Ab [Presence] in Serum

199

0.86

0.26

2.0

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.70

0.26

1.0

1.5

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.70

0.26

1.0

1.1

—

22.33

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

342

1.10

0.25

1.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

100

1.21

0.25

1.1

1.3

0.09

0.06

g/l

1.33

(3048879) Bone marrow aspiration report

599

0.93

0.25

1.2

1.6

—

(1175426) CD3 cells/100 lymphocytes in Blood

151

1018

1.06

0.25

2.1

1.9

72.31

70.30

0.86

144

959

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

429

0.91

0.25

1.0

1.1

100.07

94.56

0.47

317

(3020961) Endomysium IgA Ab [Titer] in Serum

759

5281

1.02

0.24

1.1

230.56

200.42

titre

0.11

125

(4212803) Bone marrow aspirate examination

181

1.14

0.24

1.1

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

344

1.10

0.23

1.4

1.6

88.74

130.27

ng/l

3.30

344

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

121

1.18

0.23

2.6

1.9

5.46

19.45

3.48

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

121

1.18

0.23

1.1

1.0

92.74

82.60

ug/l

0.29

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

259

1914

0.96

0.23

1.1

52.97

625.54

iu/ml

0.92

365

(3000093) Morphology [Interpretation] in Blood Narrative

255

1747

1.04

0.23

1.1

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

1.27

0.23

1.4

1.0

—

23.78

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

544

0.93

0.22

1.1

1.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

203

0.88

0.22

1.2

1.3

6.42

6.38

mmol/l

0.01

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

101

676

1.06

0.22

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

1.23

0.22

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

153

1037

1.05

0.22

1.6

6.45

6.98

u/l

0.17

117

835

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

256

1889

0.96

0.22

3.5

3.6

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.22

0.0

1.4

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

292

0.90

0.21

1.0

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

258

1771

1.04

0.21

1.2

63.39

62.84

u/l

0.04

227

1573

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.21

0.0

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.79

0.21

7.3

8.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

148

1004

1.05

0.21

1.2

10.14

9.15

mmol/l

1.57

138

956

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

146

1089

0.95

0.21

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

616

1.06

0.20

1.1

1.2

151.39

160.96

mmol/24h

0.45

616

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

170

1.13

0.20

3.2

5.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

336

2322

1.03

0.20

1.4

1.5

77843.45

56483.01

e6/l

0.45

217

1381

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

417

1.08

0.19

13.6

7.8

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

789

5513

1.02

0.19

1.6

172.50

247.96

titre

0.99

252

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

297

0.91

0.19

2.4

2.8

—

(40768806) Pleura Pathology biopsy report

305

2236

0.97

0.19

1.4

1.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

205

1.11

0.19

1.0

1.1

15.89

18.59

u/l

0.43

139

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

135

918

1.05

0.18

2.2

221.14

105.70

ug/min

0.33

211

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

139

1033

0.96

0.18

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

611

0.94

0.18

1.2

1.3

1082.27

187.97

ug/l

1.08

322

(3036670) Protein [Mass/volume] in Synovial fluid

585

1.06

0.18

1.2

39.20

39.89

g/l

0.20

298

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.73

0.17

1.2

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

670

1.05

0.17

1.2

1.4

3.74

2.38

0.67

556

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

150

1026

1.04

0.17

1.2

92.55

94.20

u/l

0.06

133

880

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.14

0.16

1.0

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

338

1.07

0.16

1.1

82.65

85.08

0.22

168

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

112

1.14

0.16

1.4

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.84

0.16

2.0

1.3

1.40

1.02

u/field

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.84

0.16

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

227

0.91

0.16

1.0

1.1

0.35

1.01

u/ml

0.73

101

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

381

0.93

0.15

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

160

0.89

0.15

1.7

3.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

234

0.91

0.15

1.0

1.1

—

(4146454) Self-monitoring of blood glucose

286

2088

0.97

0.15

2.5

2.7

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

380

0.94

0.15

1.1

1.3

0.31

g/l

0.09

303

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

264

1.08

0.14

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

144

989

1.04

0.14

3.1

3.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

125

856

1.04

0.14

3.8

3.3

—

(37021550) Renin [Units/volume] in Plasma --upright

341

1.06

0.13

1.2

37.09

71.67

mu/l

2.23

249

(3026250) Tacrolimus [Mass/volume] in Blood

494

1.05

0.13

34.0

31.7

6.56

7.17

ug/l

1.58

433

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

606

1.05

0.13

1.3

1.2

6.23

6.12

mmol/l

0.29

566

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

217

0.92

0.13

1.1

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

130

893

1.04

0.13

1.4

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

301

2189

0.98

0.13

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.81

0.13

1.4

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

156

1145

0.97

0.13

1.2

124.00

157.57

titre

0.32

210

(3026692) Albumin [Mass/volume] in Peritoneal fluid

443

0.95

0.13

1.3

1.4

11.98

14.56

g/l

1.20

345

(3011985) Renin [Units/volume] in Plasma

274

1994

0.98

0.13

1.4

69.73

53.38

mu/l

0.55

233

1758

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

165

0.91

0.12

1.1

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

130

894

1.03

0.12

1.4

1.5

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

156

1144

0.97

0.12

1.2

125.00

178.05

titre

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

130

895

1.03

0.12

2.0

2.2

465.78

555.91

e6/l

0.88

108

756

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

229

1591

1.02

0.12

1.5

21.16

28.91

3.52

150

973

(3005011) Chlamydia sp Ab [Titer] in Serum

163

1.09

0.12

1.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

605

4247

1.01

0.11

2.5

2.3

3.68

3.64

g/l

0.21

579

4033

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

443

3104

1.02

0.11

1.5

1.7

3.34

4.69

iu/l

2.98

130

959

(3033923) Metanephrine [Moles/time] in 24 hour Urine

358

1.05

0.11

1.2

1.1

0.74

0.67

umol/24h

0.30

165

(3024471) HLA-A [Type]

365

1.05

0.11

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

585

0.96

0.11

1.3

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

134

0.90

0.11

1.0

1.1

0.33

2.92

u/ml

—

109

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

714

0.97

0.10

1.1

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

387

1.05

0.10

1.1

1.2

1.67

1.57

mmol/l

0.25

241

(3019174) dRVVT (LA screen)

104

0.89

0.10

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

422

1.05

0.10

1.4

1.5

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.11

0.10

1.0

10.45

3.65

u/ml

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

332

1.05

0.09

1.1

1.2

83.77

83.06

0.04

170

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

339

1.05

0.09

1.1

1.2

103.36

101.58

0.13

311

(3042733) HLA Ab [Presence] in Serum

346

1.05

0.09

4.7

5.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.12

0.09

1.0

1.1

1.33

2.71

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.88

0.09

1.2

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

139

965

1.03

0.09

2.3

1.9

—

(40768446) Kidney Pathology biopsy report

502

0.96

0.08

1.5

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

576

4055

1.01

0.08

1.8

1.5

0.23

0.24

g/l

0.28

542

3806

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

152

1.08

0.08

2.5

1.9

61.31

59.51

0.07

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

364

0.96

0.08

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

501

0.97

0.08

1.3

1.9

181.19

167.17

0.54

463

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

123

854

1.02

0.08

2.1

2.3

0.22

0.25

e9/l

0.91

107

753

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1017

7184

1.01

0.08

1.4

1.5

17.90

17.20

u/ml

0.03

162

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.90

0.08

1.8

2.8

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.05

0.07

1.0

1.1

—

22.21

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

233

0.95

0.07

1.3

1.2

94.00

80.01

—

(3013466) aPTT in Blood by Coagulation assay

0.84

0.07

1.1

38.89

39.72

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

314

1.04

0.07

1.5

1.6

86.69

118.29

ug/l

1.49

262

(3026470) Cobalt [Mass/volume] in Blood

184

1332

0.98

0.07

1.8

2.0

2.54

3.92

ug/l

3.57

166

1219

(3007164) IgA [Mass/volume] in Serum or Plasma

3413

24206

1.00

0.07

1.5

2.78

2.61

g/l

2.42

1833

13627

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

290

0.96

0.06

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

123

857

1.02

0.06

1.1

78.24

88.14

u/l

1.06

104

760

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.10

0.06

5.0

3.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

186

1345

0.98

0.06

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

112

1.08

0.06

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

259

1.04

0.06

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

231

1.05

0.06

1.2

85.27

71.69

0.62

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

123

858

1.02

0.06

1.1

23.90

27.32

u/l

0.42

102

756

(3029396) Erythrocyte agglutination [Presence] in Blood

101

0.92

0.06

1.5

2.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

330

1.04

0.05

1.3

1.5

8.71

10.83

0.23

167

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

281

0.96

0.05

8.4

7.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

360

0.97

0.05

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

2086

14795

1.00

0.05

1.9

2.1

164.60

155.16

ug/g

0.49

1560

11452

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.08

0.05

1.8

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

141

1.06

0.05

1.3

1.2

—

(3024932) HLA-DR beta [Type]

352

1.03

0.05

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

599

1.02

0.05

1.2

1.4

24.53

19.66

0.87

533

(3025577) Chromium [Mass/volume] in Blood

183

1286

1.01

0.04

1.9

2.0

1.85

2.33

ug/l

1.80

147

1072

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.09

0.03

1.6

1.1

—

(3004775) Volume in Urine collected for unspecified duration

213

1502

1.01

0.03

2.1

2.2

720.67

662.13

0.96

126

973

(3012441) Differential panel - Pleural fluid

308

2207

0.99

0.03

1.4

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

301

2157

0.99

0.03

1.6

1.5

65.46

60.58

1.46

197

1349

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

164

1.04

0.03

4.0

4.9

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

385

0.98

0.02

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

118

830

1.01

0.02

1.6

1.5

5.12

6.66

u/l

2.97

683

(3050794) Legionella sp Ab [Presence] in Serum

134

0.96

0.02

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

191

0.97

0.02

3.2

2.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

165

1.03

0.02

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

165

1.03

0.02

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

165

1.03

0.02

1.1

1.2

—

(3006462) Nitrate [Presence] in Urine

112

804

0.99

0.01

3.8

3.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

586

4180

1.00

0.01

1.8

1.5

1.16

1.17

g/l

0.48

555

3939

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

357

1.02

0.01

1.1

1.3

111.13

113.68

0.33

311

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

390

0.99

0.01

1.1

1.2

257.26

269.73

pmol/l

0.13

274

(21494567) Legionella sp IgM Ab [Presence] in Serum

109

1.04

0.01

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

109

1.04

0.01

1.8

4.6

—

(3011412) CD3 cells [#/volume] in Blood

187

1337

1.00

0.01

2.2

2.1

1.10

1.17

e9/l

0.30

166

1218

(3038071) Oxygen [Partial pressure] in Mixed venous blood

351

1.01

0.00

15.3

7.8

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

141

999

1.00

0.00

2.2

2.3

648.67

649.01

e6/l

0.00

135

948

(3044009) aPTT.lupus sensitive (LA screen)

103

1.04

0.00

1.3

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

122

0.99

0.00

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

475

1.00

0.00

2.0

2.6

17.82

21.63

mu/l

0.57

439

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

288

2048

1.00

0.00

1.2

292.75

283.86

u/ml

0.21

175

1261

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.05

0.00

1.3

1.6

—

(3012565) Volume of 24 hour Urine

116

827

1.00

0.00

1.9

2.2

1944.90

1871.10

0.18

709

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

107

1.00

0.00

1.0

0.51

0.79

u/ml

—

(3016330) Potassium [Moles/time] in 24 hour Urine

201

0.99

0.00

1.3

1.2

—

74.40

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

164

1.00

0.00

1.0

1.2

1.86

1.71

umol/24h

0.26

164

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

221

1.00

0.00

1.1

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

245

0.99

0.00

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

285

1.00

0.00

1.1

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

366

0.99

0.00

1.8

1.6

10.44

9.34

ug/l

0.77

366

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

106

1.01

0.00

1.4

1.3

0.16

0.15

nmol/l

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

108

0.99

0.00

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

610

1.00

0.00

1.1

1.07

1.08

ratio

0.30

203

(3016750) Collection duration of Urine

151

1077

1.00

0.00

2.1

518.35

497.71

min

1.83

762

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.91

0.00

1.5

1.3

1.33

1.24

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.2

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.91

0.00

1.0

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.93

-0.00

1.4

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

6.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.91

-0.00

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

1.00

-0.00

6.3

5.9

428.86

431.46

umol/l

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.0

—

2.51

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: F5_ORGANIC – Organic, including symptomatic, mental disorders

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Organic, including symptomatic, mental disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints